Substance use disorders in the U.S. armed forces

Substance Use Disorders in the U.S. Armed Forces

Volumn , Issue , 2013, Pages 1-390

  O'Brien, Charles P ^a   Oster, Maryjo M ^b   Morden, Emily C ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b IOM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84990298335     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.17226/13441     Document Type: Book

References (497)

1. IOM (Institute of Medicine). 2006. Improving the quality of health care for mental and substance-use conditions: Quality chasm series. Washington, DC: The National Academies Press.
2. VA (Department of Veterans Affairs) and DoD (Department of Defense). 2009. VA/DoD clinical practice guideline for management of substance use disorders. Washington, DC: VA and DoD.
3. Blume, A. W., K. B. Schmaling, and M. L. Russell. 2010. Stress and alcohol use among soldiers assessed at mobilization and demobilization. Military Medicine 175 (6):400-404.
4. Bray, R. M., M. R. Pemberton, L. L. Hourani, M. Witt, K. L. Olmsted, J. M. Brown, B. Weimer, M. E. Lance, M. E. Marsden, and S. Scheffler. 2009. Department of Defense survey of health related behaviors among active duty military personnel. Research Triangle Park, NC: RTI International.
5. Bray, R. M., M. R. Pemberton, M. E. Lane, L. L. Hourani, M. J. Mattiko, and L. A. Babeu. 2010. Substance use and mental health trends among U.S. military active duty personnel: Key findings from the 2008 DoD Health Behavior Survey. Military Medicine 175 (6):390-399.
6. Brewin, B. 2011. Military's drug policy threatens troops' health, doctors say. Nextgov, http:// www.nextgov.com/health/2011/01/militarys-drug-policy-threatens-troops-health-doctorssay/ 48321/ (accessed June 12, 2012).
7. DoD (Department of Defense). 2009. Status of drug use in the Department of Defense personnel. Falls Church, VA: DoD.
8. DoD. 2011. Comprehensive plan on prevention, diagnosis, and treatment of substance use disorders and disposition of substance use offenders in the armed forces. Washington, DC: Office of the Under Secretary of Defense.
9. Horgan, C. M., G. Strickler, and K. Skwara. 2001. Substance abuse: The nation's number one health problem. Key indicators for policy-update. Waltham, MA: Heller School, Brandeis University.
10. IOM (Institute of Medicine). 2009. Combatting tobacco in military and veteran populations. Washington, DC: The National Academies Press.
11. IOM. 2010. Returning home from Iraq and Afghanistan: Preliminary assessment of readjustment needs of veterans, service members, and their families. Washington, DC: The National Academies Press.
12. Manchikanti, L., and A. Singh. 2008. Therapeutic opioids: A ten-year perspective on the complexitiesand complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 11 (Suppl. 2):S63-S88.
13. Marshall, B. D. L., M. R. Prescott, I. Liberzon, M. B. Tamburrino, J. R. Calabrese, and S. Galea. 2012. Coincident posttraumatic stress disorder and depression predict alcohol abuse during and after deployment among Army National Guard soldiers. Drug and Alcohol Dependence [Epub ahead of print].
14. Office of the Surgeon General. 2004. 2004 Surgeon General's report-the health consequences of smoking. Atlanta, GA: Office of the Surgeon General.
15. Rosenbaum, C. D., S. P. Carreiro, and K. M. Babu. 2012. Here today, gone tomorrow. And back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, salvia divinorum, methoxetamine, and piperazines. Journal of Medical Toxicology 8 (1):15-32.
16. SAMHSA (Substance Abuse and Mental Health Services Administration). 2011. Results from the 2010 National Survey on Drug Use and Health: Summary of national findings. Rockville, MD: SAMHSA.
17. U.S. Air Force Special Operations Command. 2011. AFSOC to airmen: Use Spice, may lose career.Air Force Print News Today, http://www.afsoc.af.mil/news/story.asp?id=123255852 (accessed June 12, 2012).
18. U.S. Army. 2012. Army 2020: Generating health & discipline in the force. Washington, DC: U.S. Army.
19. VA (Department of Veterans Affairs) and DoD. 2009. VA/DoD clinical practice guideline for management of substance use disorders. Washington, DC: VA and DoD.
20. Zoroya, G. 2010. Abuse of pain pills by troops concerns Pentagon. USA Today, March 17, http://www.usatoday.com/news/military/2010-03-16-military-drugs_N.htm (accessed June 27, 2012).
21. Adams, R. S., M. J. Larson, J. Corrigan, C. Horgan, and T. Williams. 2012. Frequent binge drinking after combat-acquired traumatic brain injury among active duty military personnel with a past year combat deployment. Journal of Head Trauma and Rehabilitation 27 (5):349-360.
22. Ahmadi, H., and S. L. Green. 2011. Screening, brief intervention, and referral to treatment for military spouses experiencing alcohol and substance use disorders: A literature review. Journal of Clinical Psychology in Medical Settings 18 (2):129-136.
23. Allen, J., and J. Mazzuchi. 1985. Alcohol and drug abuse among American military personnel: Prevalence and policy implications. Military Medicine 150 (5):250-255.
24. Ames, G. M., and C. Cunradi. 2004. Alcohol use and preventing alcohol-related problems among young adults in the military. Alcohol Research & Health 28 (4):252-257.
25. Ames, G. M., M. R. Duke, R. S. Moore, and C. B. Cunradi. 2009. The impact of occupational culture on drinking behavior of young adults in the U.S. Navy. Journal of Mixed Methods Research 3 (2):129-150.
26. Anthony, J. C., L. A. Warner, and R. C. Kessler. 1994. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology 2 (3):244-268.
27. APA (American Psychiatric Association). 2011. DSM-5 development. http://www.dsm5.org/ ProposedRevisions/Pages/proposedrevision.aspx?rid=431 (accessed August 10, 2011).
28. Armed Forces Health Surveillance Center. 2011. Alcohol-related diagnoses, active component, U.S. Armed Forces, 2001-2010. Medical Surveillance Monthly Report 18 (10):9-13.
29. Armed Forces Health Surveillance Center. 2012a. Absolute and relative morbidity burdens attributable to various illnesses and injuries, U.S. Armed Forces, 2011. Medical Surveillance Monthly Report 19 (4):4-9.
30. Armed Forces Health Surveillance Center. 2012b. Surveillance snapshot: Recurrent medical encounters associated with alcohol abuse-related diagnostic codes, active component, U.S. Armed Forces, 2001-2010. Medical Surveillance Monthly Report 19(2):23.
31. Babor, T. 2001. AUDIT, the alcohol use disorders identification test: Guidelines for use in primary care (2nd ed.). Geneva, Switzerland: World Health Organization, Department of Mental Health and Substance Dependence.
32. Brady, J. V., and R. R. Griffiths. 1983. Testing drugs for abuse liability and behavioral toxicity: Progress report from the laboratories at the Johns Hopkins University School of Medicine. NIDA Research Monograph 43:99-124.
33. Brady, K. T., T. K. Killeen, T. Brewerton, and S. Lucerini. 2000. Comorbidity of psychiatric disorders and posttraumatic stress disorder. Journal of Clinical Psychiatry 61 (Suppl. 7):22-32.
34. Brandt, A. M. 2007. The cigarette century: The rise, fall, and deadly persistence of the product that defined America. New York: Basic Books. http://site.ebrary.com/lib/alltitles/doc Detail.action?docID=10263798 (accessed June 12, 2012).
35. Bray, R. M., M. R. Pemberton, L. L. Hourani, M. Witt, K. L. Olmsted, J. M. Brown, B. Weimer, M. E. Lance, M. E. Marsden, and S. Scheffler. 2009. Department of Defense Survey of Health Related Behaviors among Active Duty Military Personnel. Research Triangle Park, NC: RTI International. http://www.tricare.mil/2008HealthBehaviors.pdf (accessed June 11, 2012).
36. Bray, R. M., M. R. Pemberton, M. E. Lane, L. L. Hourani, M. J. Mattiko, and L. A. Babeu. 2010a. Substance use and mental health trends among U.S. military active duty personnel: Key findings from the 2008 DoD Health Behavior Survey. Military Medicine 175 (6):390-399.
37. Bray, R. M., J. L. Spira, K. R. Olmsted, and J. J. Hout. 2010b. Behavioral and occupational fitness. Military Medicine 175 (Suppl. 1):39-56.
38. Bray, R. M., K. L. Rae Olmsted, and J. Williams. 2012. Misuse of prescription pain medications in U.S. active-duty service members: From recruitment to returning troops. In Pain syndromes-from recruitment to returning troops, edited by B. K. Wiederhold, Vol. 91. Amsterdam: IOS Press.
39. Bryant, C. D. 1974. Olive-drab drunks and GI junkies: Alcohol and narcotic addiction in the U.S. military. In Deviant behavior: Occupational and organizational bases, edited by C. D. Bryant. Chicago, IL: Rand McNally.
40. Bryant, C. D. 1979. Khaki-collar crime: Deviant behavior in the military context. New York: Free Press.
41. Burnett-Zeigler, I., M. Ilgen, M. Valenstein, K. Zivin, L. Gorman, A. Blow, S. Duffy, and S. Chermack. 2011. Prevalence and correlates of alcohol misuse among returning Afghanistan and Iraq veterans. Addictive Behaviors 36 (8):801-806.
42. Campbell, D. G., B. L. Felker, C. F. Liu, E. M. Yano, J. E. Kirchner, D. Chan, L. V. Rubenstein, and E. F. Chaney. 2007. Prevalence of depression-PTSD comorbidity: Implications for clinical practice guidelines and primary care-based interventions. Journal of General Internal Medicine 22 (6):711-718.
43. Conway, T. L. 1998. Tobacco use and the United States military: A longstanding problem. Tobacco Control 7 (3):219-221.
44. Defense Health Board. 2011. Psychotropic medication prescription practices and use and complementary and alternative medicine use. Falls Church, VA: Defense Health Board.
45. DoD (Department of Defense). 1970. Directive 1300.11: Illegal or improper use of drugs by members of the Department of Defense. Washington, DC: DoD.
46. DoD. 1972. Directive 1010.2: Alcohol abuse by personnel of the Department of Defense. Washington, DC: DoD.
47. DoD. 1980. Directive 1010.4: Alcohol and drug abuse by DoD personnel. Washington, DC: DoD.
48. DoD. 1986a. Directive 1010.10: Health promotion. Washington, DC: DoD.
49. DoD. 1986b. Smoking and health in the military. Washington, DC: DoD.
50. DoD. 1987. Department of Defense updated report on smoking and health in the military. Washington, DC: DoD.
51. DoD. 1994. Instruction 1010.15: Smoke-free DoD facilities. Washington, DC: DoD.
52. DoD. 1997. Directive 1010.4: Drug and alcohol abuse by DoD personnel. Washington, DC: DoD.
53. DoD. 2009. Status of drug use in the Department of Defense personnel. Falls Church, VA: DoD.
54. DoD. 2011a. Demographics 2010: Profile of the military community. Arlington, VA: DoD.
55. DoD. 2011b. Comprehensive plan on prevention, diagnosis, and treatment of substance use disorders and disposition of substance use offenders in the armed forces. Washington, DC: Office of the Under Secretary of Defense.
56. DoD. 2012. The Millennium Cohort Study. http://www.millenniumcohort.org/index.php (accessedJuly 23, 2012).
57. Eaton, K. M., C. W. Hoge, S. C. Messer, A. A. Whitt, O. A. Cabrera, D. McGurk, A. Cox, and C. A. Castro. 2008. Prevalence of mental health problems, treatment need, and barriers to care among primary care-seeking spouses of military service members involved in Iraq and Afghanistan deployments. Military Medicine 173 (11):1051-1056.
58. Fattore, L., and W. Fratta. 2011. Beyond THC: The new generation of cannabinoid designer drugs. Frontiers in Behavioral Neuroscience 5:60.
59. Floen, S. K., and A. Elklit. 2007. Psychiatric diagnoses, trauma, and suicidiality. Annals of General Psychiatry 6 (12).
60. Foa, E. B. 2009. Effective treatments for PTSD: Practice guidelines from the International Society for Traumatic Stress Studies. New York: Guilford Press.
61. Fontana, A., and R. Rosenheck. 2008. Treatment-seeking veterans of Iraq and Afghanistan: Comparison with veterans of previous wars. Journal of Nervous and Mental Disease 196 (7):513-521.
62. Gibbs, D. A., S. L. Martin, L. L. Kupper, and R. E. Johnson. 2007. Child maltreatment in enlisted soldiers' families during combat-related deployments. Journal of the American Medical Association 298 (5):528-535.
63. Goldman, D., G. Oroszi, and F. Ducci. 2005. The genetics of addictions: Uncovering the genes. Nature Reviews Genetics 6 (7):521-532.
64. Hasin, D. S. 2012. Introduction to DSM-5 criteria linked papers in drug and alcohol dependence. Drug and Alcohol Dependence 122 (1-2):20-21.
65. Horgan, C. M., G. Strickler, and K. Skwara. 2001. Substance abuse: The nation's number one health problem-key indicators for policy-update. Schneider Insitute for Health Policy. Waltham, MA: Heller School, Brandeis University.
66. Hourani, L. L., R. M. Bray, M. E. Marsden, M. Witt, R. Vandermaas-Peeler, S. Scheffler, K. Rae Olmsted, B. Weimer, J. M. Brown, M. R. Pemberton, S. J. Nielsen, B. Lane, K. Aspinwall, S. Jones, and L. Strange. 2007. Department of Defense survey of health Related behaviors among the Guard and Reserve Force. Research Triangle Park, NC: RTI International. http://www.tricare.mil/hpae/_docs/RC_2006%20Reserve%20Component_FR_9-07.pdf (accessed May 24, 2012).
67. Ingraham, L. H., and F. J. Manning. 1984. The boys in the barracks: Observations on American military life. Philadelphia, PA: Institute for the Study of Human Issues.
68. IOM (Institute of Medicine). 1990. Broadening the base of treatment for alcohol problems. Washington, DC: National Academy Press.
69. IOM. 1994. Under the influence?: Drugs and the American work force. Summary: Conclusion and recommendations. Washington, DC: National Academy Press.
70. IOM. 1996. Pathways of addiction: Opportunities in drug abuse research. Washington, DC: National Academy Press.
71. IOM. 2009. Combating tobacco use in military and veteran populations. Washington, DC: The National Academies Press.
72. IOM. 2010. Returning home from Iraq and Afghanistan: Preliminary assessment of readjustmentneeds of veterans, service members, and their families. Washington, DC: The National Academies Press.
73. IOM and NRC (National Research Council). 2004. New treatments for addiction: Behavioral, ethical, legal, and social questions. Washington, DC: The National Academies Press.
74. Jacobson, I. G., M. A. K. Ryan, T. I. Hooper, T. C. Smith, P. J. Amoroso, E. J. Boyko, G. D. Gackstetter, T. S. Wells, and N. S. Bell. 2008. Alcohol use and alcohol-related problems before and after military combat deployment. Journal of the American Medical Association 300 (6):663-675.
75. Jakovljevic, M., M. Saric, S. Nad, R. Topic, and B. Vuksan-Cusa. 2006. Metabolic syndrome, somatic and psychiatric comorbidity in war veterans with post-traumatic stress disorder: Preliminary findings. Psychiatria Danubina 18 (3-4):169-176.
76. Kasick, D. P., C. A. McKnight, and E. Klisovic. 2012. "Bath salt" ingestion leading to severe intoxication delirium: Two cases and a brief review of the emergence of mephedrone use. American Journal of Drug and Alcohol Abuse 38 (2):176-180.
77. Keane, T. M., and J. Wolfe. 1990. Comorbidity in post-traumatic stress disorder an analysis of community and clinical studies. Journal of Applied Social Psychology 20 (21):1776-1788.
78. KLEAN Treatment Center. 2012. Spice: Military adopts no tolerance policy. www.klean treatmentcenter.com/spice-military-adopts-no-tolerance-policy (accessed May 24, 2012).
79. Koob, G. F., and F. E. Bloom. 1988. Cellular and molecular mechanisms of drug dependence. Science 242 (4879):715-723.
80. Kroutil, L. A., R. M. Bray, and M. E. Marsden. 1994. Cigarette smoking in the U.S. military: Findings from the 1992 Worldwide Survey. Preventive Medicine 23 (4):521-528.
81. Lande, R. G., B. A. Marin, A. S. Chang, and G. R. Lande. 2008. Survey of alcohol use in the U.S. Army. Journal of Addictive Diseases 27 (3):115-121.
82. Ludwig, A. M., F. Bendfeldt, A. Wikler, and R. B. Cain. 1978. "Loss of control" in alcoholics. Archives of General Psychiatry 35 (3):370-373.
83. Maclean, P. D. 1955. The limbic system (visceral brain) in relation to central gray and reticulum of the brain stem; evidence of interdependence in emotional processes. Psychosomatic Medicine 17 (5):355-366.
84. Manchikanti, L. 2007. National drug control policy and prescription drug abuse: Facts and fallacies. Pain Physician 10 (3):399-424.
85. Manchikanti, L., and A. Singh. 2008. Therapeutic opioids: A ten-year perspective on the complexitiesand complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 11 (Suppl. 2):S63-S88.
86. Mansfield, A. J., and C. C. Engel. 2011. Understanding substance use in military spouses. Journal of Clinical Psychology in Medical Settings 18 (2):198-199.
87. Mattiko, M. J., K. L. R. Olmsted, J. M. Brown, and R. M. Bray. 2011. Alcohol use and negative consequences among active duty military personnel. Addictive Behaviors 36 (6):608-614.
88. NIAAA (National Institute on Alcohol Abuse and Alcoholism). 2005. Helping patients who drink too much: A clinician's guide. Bethesda, MD: NIAAA.
89. O'Brien, C. P. 2012. If addictions can be treated, why aren't they? http://www.dana.org/news/ features/detail_rop.aspx?id=39154 (accessed August 28, 2012).
90. O'Brien, C. P., and A. T. McLellan. 1996. Myths about the treatment of addiction. Lancet 347 (8996):237-240.
91. Office of the Surgeon General. 1967. The health consequences of smoking: A public health service review. Atlanta, GA: National Clearinghouse for Smoking and Health.
92. Office of the Surgeon General. 1979. Smoking and health: A report of the Surgeon General. http://profiles.nlm.nih.gov/ps/access/NNBCMD.pdf (accessed June 27, 2012).
93. Office of the Surgeon General. 2004. 2004 Surgeon General's report-the health consequences of smoking. Atlanta, GA: U.S. Public Health Service, Office on Smoking and Health.
94. Olds, J. 1958. Self-stimulation of the brain: Its use to study local effects of hunger, sex, and drugs. Science 127 (3294):315-324.
95. Padden, D. L., R. A. Connors, and J. G. Agazio. 2011. Determinants of health-promoting behaviors in military spouses during deployment separation. Military Medicine 176 (1): 26-34.
96. Ritz, M. C., R. J. Lamb, S. R. Goldberg, and M. J. Kuhar. 1987. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237 (4819):1219-1223.
97. Robins, L. N. 1974. The Vietnam drug user returns. Final report. Washington, DC: Special Action Office for Drug Abuse Prevention.
98. Robins, L. N., J. E. Helzer, and D. H. Davis. 1975. Narcotic use in southeast Asia and afterward. An interview study of 898 Vietnam returnees. Archives of General Psychiatry 32 (8):955-961.
99. SAMHSA (Substance Abuse and Mental Health Services Administration). 2008. Results from the 2007 National Survey on Drug Use and Health: National Findings. Rockville, MD: Office of Applied Studies, Substance Abuse and Mental Health Services Administration.
100. Santiago, P. N., J. E. Wilk, C. S. Milliken, C. A. Castro, C. C. Engel, and C. W. Hoge. 2010. Screening for alcohol misuse and alcohol-related behaviors among combat veterans. Psychiatric Services 61 (6):575-581.
101. Saunders, J. B., O. G. Aasland, T. F. Babor, J. R. De La Fuente, and M. Grant. 1993. Developmentof the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 88 (6):791-804.
102. Schuckit, M. A. 1977. Alcohol problems in the United States armed forces. Military Chaplain's Review: Alcohol Abuse (Winter):9-19.
103. Schumm, W. R., D. B. Bell, and P. A. Gade. 2000. Effects of a military overseas peacekeeping deployment on marital quality, satisfaction, and stability. Psychological Reports 87 (3, Part 1):815-821.
104. Shen, Y.-C., J. Arkes, and T. V. Williams. 2012. Effects of Iraq/Afghanistan Deployments on Major Depression and Substance Use Disorder: Analysis of Active Duty Personnel in the US Military. American Journal of Public Health 102 (S1):S80-S87.
105. Spera, C. 2011. Relationship of military deployment recency, frequency, duration, and combat exposure to alcohol use in the Air Force. Journal of Studies on Alcohol and Drugs 72 (1):5-14.
106. Tanielian, T. L., L. Jaycox, T. L. Schell, G. N. Marshall, M. A. Burnam, C. Eibner, B. R. Karney, L. S. Meredith, J. S. Ringel, and M. E. Vaiana. 2008. Invisible wounds of war: Summary and recommendations for addressing psychological and cognitive injuries. Santa Monica, CA: RAND Corporation, Center for Military Health Policy Research.
107. Thomas, J. L., J. E. Wilk, L. A. Riviere, D. McGurk, C. A. Castro, and C. W. Hoge. 2010. Prevalence of mental health problems and functional impairment among active component and National Guard soldiers 3 and 12 months following combat in Iraq. Archives of General Psychiatry 67 (6):614-623.
108. U.S. Army. 2012. Army 2020: Generating health & discipline in the force. Washington, DC: Department of the Army.
109. Vandrey, R., K. E. Dunn, J. A. Fry, and E. R. Girling. 2012. A survey study to characterize use of Spice products (synthetic cannabinoids). Drug and Alcohol Dependence 120 (1-3):238-241.
110. Volkow, N. D. 2011. "Bath salts": Emerging and dangerous products. Messages from the director, http://www.drugabuse.gov/about-nida/directors-page/messages-director/2011/02/ bath-salts-emerging-dangerous-product (accessed June 13, 2012).
111. Wells, D. L., and C. A. Ott. 2011. The "new" marijuana. Annals of Pharmacotherapy 45 (3):414-417.
112. Wertsch, M. E. 1991. Military brats: Legacies of childhood inside the fortress (1st ed.). New York: Harmony Books.
113. Winder, G. S., N. Stern, and A. Hosanagar. 2012. Are "bath salts" the next generation of stimulant abuse? Journal of Substance Abuse Treatment [Epub ahead of print].
114. DoD (Department of Defense). 1985. Instruction 1010.6: Rehabilitation and referral services for alcohol and drug abusers. Washington, DC: DoD.
115. DoD. 1994. Directive 1010.1: Drug abuse testing program. Washington, DC: DoD.
116. DoD. 1997. Directive 1010.4: Drug and alcohol abuse by DoD personnel. Washington, DC: DoD.
117. GAO (U.S. Government Accountability Office). 2011. Defense health care: Access to civilian providers under TRICARE standard and extra. Washington, DC: GAO.
118. Jansen, D. 2009. Military medical care: Questions and answers. Washington, DC: CongressionalResearch Service.
119. TMA (TRICARE Management Activity). 2008. TRICARE policy manual 6010.57-M. Falls Church, VA: TMA.
120. TMA. 2010. Treatment for substance use disorders. http://tricare.mil/substanceusedisorders (accessed May 24, 2012).
121. TMA. 2011a. Evaluation of the TRICARE program: FY 2011 report to Congress. http://www. tricare.mil/tma/downloads/TRICARE2011_02_28_11v8.pdf (accessed June 27, 2012).
122. TMA. 2011b. TRICARE prime and TRICARE remote handbook. Falls Church, VA: TMA.
123. TMA. 2012a. TRICARE for life. http://www.tricare.mil/mybenefit/home/overview/Learn AboutPlansAndCosts/TRICAREForLife (accessed June 14, 2012).
124. TMA.2012b.TRICAREpharmacyprogram.http://www.tricare.mil/mybenefit/home/Prescriptions/PharmacyProgram (accessed June 14, 2012).
125. TMA. 2012c. TRICARE standard and extra. http://www.tricare.mil/standardextra (accessed June 14, 2012).
126. Altice, F. L., R. D. Bruce, G. M. Lucas, P. J. Lum, P. T. Korthuis, T. P. Flanigan, C. O. Cunningham, L. E. Sullivan, P. Vergara-Rodriguez, D. A. Fiellin, A. Cajina, M. Botsko, V. Nandi, M. N. Gourevitch, and R. Finkelstein. 2011. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: Results from a multisite study. Journal of Acquired Immune Deficiency Syndromes 56 (Suppl. 1):S22-S32.
127. APA (American Psychiatric Association). 1994. Diagnostic and statistical manual of mental disorders: DSM-IV (4th ed.). Washington, DC: American Psychiatric Association.
128. ASAM (American Society of Addiction Medicine). 2012. Patient placement criteria. http:// www.asam.org/publications/patient-placement-criteria (accessed May 29, 2012).
129. Barry, C. L., and H. A. Huskamp. 2011. Moving beyond parity-mental health and addiction care under the ACA. New England Journal of Medicine 365 (11):973-975.
130. Brucker, D. L., and M. Stewart. 2011. Performance-based contracting within a state substance abuse treatment system: A preliminary exploration of differences in client access and client outcomes. Journal of Behavioral Health Services & Research 38 (3):383-397.
131. Buck, J. A. 2011. The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act. Health Affairs 30 (8):1402-1410.
132. Capoccia, V. A., F. Cotter, D. H. Gustafson, E. F. Cassidy, J. H. Ford, L. Madden, B. H. Owens, S. O. Farnum, D. McCarty, and T. Molfenter. 2007. Making "stone soup": Improvements in clinic access and retention in addiction treatment. Joint Commission Journal on Quality and Patient Safety 33 (2):95-103.
133. Collins, C. 2010. Evolving models of behavioral health integration in primary care. New York:Milbank Memorial Fund.
134. Fiellin, D. A., L. Weiss, M. Botsko, J. E. Egan, F. L. Altice, L. B. Bazerman, A. Chaudhry, C. O. Cunningham, M. N. Gourevitch, P. J. Lum, L. E. Sullivan, R. S. Schottenfeld, and P. G. O'Connor. 2011. Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone. Journal of Acquired Immune Deficiency Syndromes 56 (Suppl. 1):S33-S38.
135. Fishman, M. 2010. Treatment planning, matching and placement for adolescent substance abuse. In Clinical manual of adolescent substance abuse treatment, edited by Y. Kaminer and K. Winters. Arlington, VA: American Psychiatric Publishing. Pp. 113-135.
136. Garfield, R. L., S. H. Zuvekas, J. R. Lave, and J. M. Donohue. 2011. The impact of national health care reform on adults with severe mental disorders. American Journal of Psychiatry 168 (5):486-494.
137. Goldman, H. H., R. G. Frank, M. A. Burnam, H. A. Huskamp, M. S. Ridgely, S. L. T. Normand, A. S. Young, C. L. Barry, V. Azzone, A. B. Busch, S. T. Azrin, G. Moran, C. Lichtenstein, and M. Blasinsky. 2006. Behavioral health insurance parity for federal employees. New England Journal of Medicine 354 (13):1378-1386.
138. Gourevitch, M. N., and J. H. Arnsten. 2005. Medical complications of drug use. In Substance abuse: A comprehensive textbook, edited by J. H. Lowinson. Philadelphia, PA: Lippincott Williams & Wilkins.
139. Gustafson, D. H., and K. Johnson. 2012. The NIATx model: Process improvement for behavioral health. Madison, WI: Wisconsin-Madison's Center for Health Enhancement Systems Studies.
140. Hoffman, K. A., J. H. Ford, 2nd, D. Choi, D. H. Gustafson, and D. McCarty. 2008. Replication and sustainability of improved access and retention within the network for the improvement of addiction treatment. Drug and Alcohol Dependence 98 (1-2):63-69.
141. Hoffman, N. G., J. A. Halikas, D. Mee-Lee, and R. D. Weedman. 1991. Patient placement criteria for the treatment of psychoactive substance use disorders. Washington, DC: ASAM.
142. Humphreys, K., and A. T. McLellan. 2011. A policy-oriented review of strategies for improving the outcomes of services for substance use disorder patients. Addiction 106:2058-2066.
143. IOM (Institute of Medicine). 2000. To err is human: Building a safer health system. Washington, DC: National Academy Press.
144. IOM. 2001. Crossing the quality chasm: A new health system for the 21st century. Washington, DC: National Academy Press.
145. IOM. 2006. Improving the quality of health care for mental and substance-use conditions: Quality chasm series. Washington, DC: The National Academies Press.
146. Korthuis, P. T., J. Gregg, W. E. Rogers, D. McCarty, C. Nicolaidis, and J. Boverman. 2010. Patients' reasons for choosing office-based buprenorphine: Preference for patient-centered care. Journal of Addiction Medicine 4 (4):204-210.
147. Korthuis, P. T., D. A. Fiellin, R. Fu, P. J. Lum, F. L. Altice, N. Sohler, M. J. Tozzi, S. M. Asch, M. Botsko, M. Fishl, T. P. Flanigan, J. Boverman, and D. McCarty. 2011a. Improving adherence to HIV quality of care indicators in persons with opioid dependence: The role of buprenorphine. Journal of Acquired Immune Deficiency Syndromes 56 (Suppl. 1):S83-S90.
148. Korthuis, P. T., M. J. Tozzi, V. Nandi, D. A. Fiellin, L. Weiss, J. E. Egan, M. Botsko, A. Acosta, M. N. Gourevitch, D. Hersh, J. Hsu, J. Boverman, and F. L. Altice. 2011b. Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics. Journal of Acquired Immune Deficiency Syndromes 56 (Suppl. 1):S39-S45.
149. Manwell, L. B., M. F. Fleming, K. Johnson, and K. L. Barry. 1998. Tobacco, alcohol, and drug use in a primary care sample: 90-day prevalence and associated factors. Journal of Addictive Disorders 17 (1):67-81.
150. McCarty, D., B. E. Fuller, C. Arfken, M. Miller, E. V. Nunes, E. Edmundson, M. Copersino, A. Floyd, R. Forman, R. Laws, K. M. Magruder, M. Oyama, K. Prather, J. Sindelar, and W. W. Wendt. 2007a. Direct care workers in the national drug abuse treatment clinical trials network: Characteristics, opinions, and beliefs. Psychiatric Services 58 (2):181-190.
151. McCarty, D., D. H. Gustafson, J. P. Wisdom, J. Ford, D. Choi, T. Molfenter, V. Capoccia, and F. Cotter. 2007b. The Network for the Improvement of Addiction Treatment (NIATx): Enhancing access and retention. Drug and Alcohol Dependence 88 (2-3):138-145.
152. McCarty, D., K. J. McConnell, and L. A. Schmidt. 2010. Priorities for policy research on treatments for alcohol and drug use disorders. Journal of Substance Abuse Treatment 39 (2):87-95.
153. McConnell, K. J., S. H. N. Gast, M. S. Ridgely, N. Wallace, N. Jacuzzi, T. Rieckmann, B. H. McFarland, and D. McCarty. 2011. Behavioral health insurance parity: Does Oregon's experience presage the national experience with the Mental Health Parity and Addiction Equity Act? American Journal of Psychiatry 169 (1):31-38.
154. McGlynn, E. A., S. M. Asch, J. Adams, J. Keesey, J. Hicks, A. DeCristofaro, and E. A. Kerr. 2003. The quality of health care delivered to adults in the United States. New England Journal of Medicine 348 (26):2635-2645.
155. Mee-Lee, D. 2001. ASAM patient placement criteria for the treatment of substance-related disorders (2nd rev. ed.). Chevy Chase, MD: ASAM.
156. NCQA (National Committee for Quality Assurance). 2012. Accountable Care Organizations (ACOs). http://www.ncqa.org/tabid/1312/Default.aspx (accessed May 29, 2012).
157. NQF (National Quality Forum). 2007. National voluntary consensus standards for the treatment of substance use conditions: Evidence-based treatment practices. Washington, DC: NQF.
158. O'Connor, P. G., and J. H. Samet. 2002. Substance abuse: The expanding role of general internal medicine. Journal of General Internal Medicine 17 (5):398-399.
159. ONDCP (Office of National Drug Control Policy). 2010. National drug control strategy, 2010. Washington, DC: ONDCP.
160. ONDCP. 2011. National drug control strategy, 2011. Washington, DC: ONDCP.
161. ONDCP. 2012. National drug control strategy, 2012. Washington, DC: ONDCP.
162. Sommers, B. D., K. Swartz, and A. Epstein. 2011. Policy makers should prepare for major uncertaintiesin Medicaid enrollment, costs, and needs for physicians under health reform. Health Affairs 30 (11):2186-2193.
163. VA (Department of Veterans Affairs) and DoD (Department of Defense). 2009. VA/DoD clinical practice guideline for management of substance use disorders. Washington, DC: VA and DoD.
164. Weisner, C. M., C. I. Campbell, G. T. Ray, K. Saunders, J. O. Merrill, C. Banta-Green, M. D. Sullivan, M. J. Silverberg, J. R. Mertens, D. Boudreau, and M. Von Korff. 2009. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain 145 (3):287-293.
165. Adams, N. J., M. B. Plane, M. F. Fleming, M. P. Mundt, L. A. Saunders, and E. A. Stauffacher. 2001. Opioids and the treatment of chronic pain in a primary care sample. Journal of Pain and Symptom Management 22 (3):791-796.
166. Ahmadi, H., and S. L. Green. 2011. Screening, brief intervention, and referral to treatment for military spouses experiencing alcohol and substance use disorders: A literature review. Journal of Clinical Psychology in Medical Settings 18 (2):129-136.
167. Ajzen, I., and M. Fishbein. 1980. Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ: Prentice-Hall.
168. Allen, J., R. F. Anton, T. F. Babor, J. Carbonari, K. M. Carroll, G. J. Connors, N. L. Cooney, F. K. Del Boca, C. C. DiClemente, D. Donovan, R. M. Kadden, M. Litt, R. Longabaugh, M. Mattson, W. R. Miller, C. L. Randall, B. J. Rounsaville, R. G. Rychtarik, R. L. Stout, J. S. Tonigan, P. W. Wirtz, and A. Zweben. 1998. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research 22 (6):1300-1311.
169. Amaro, H., J. Dai, S. Arevalo, A. Acevedo, A. Matsumoto, R. Nieves, and G. Prado. 2007. Effects of integrated trauma treatment on outcomes in a racially/ethnically diverse sample of women in urban community-based substance abuse treatment. Journal of Urban Health 84 (4):508-522.
170. Amass, L., W. Ling, T. E. Freese, C. Reiber, J. J. Annon, A. J. Cohen, D. McCarty, M. S. Reid, L. S. Brown, Jr., C. Clark, D. M. Ziedonis, J. Krejci, S. Stine, T. Winhusen, G. Brigham, D. Babcock, J. A. Muir, B. J. Buchan, and T. Horton. 2004. Bringing buprenorphinenaloxone detoxification to community treatment providers: The NIDA clinical trials network field experience. American Journal on Addictions 13 (Suppl. 1):S42-S66.
171. Amato, L., S. Minozzi, M. Davoli, S. Vecchi, M. M. F. Ferri, and S. Mayet. 2008. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database of Systematic Reviews 4.
172. Anton, R. F., S. S. O'Malley, D. A. Ciraulo, R. A. Cisler, D. Couper, D. M. Donovan, D. R. Gastfriend, J. D. Hosking, B. A. Johnson, J. S. LoCastro, R. Longabaugh, B. J. Mason, M. E. Mattson, W. R. Miller, H. M. Pettinati, C. L. Randall, R. Swift, R. D. Weiss, L. D. Williams, A. Zweben, and C. S. R. Group. 2006. Combined pharmacotherapies and behavioral interventions for alcohol dependence: The combine study: A randomized controlled trial. Journal of the American Medical Association 295 (17):2003-2017.
173. APA (American Psychiatric Association). 2000. Diagnostic and statistical manual of mental disorders, fourth edition, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
174. APA. 2012. DSM-5: The future of psychiatric diagnosis. http://www.dsm5.org/Pages/Default. aspx (accessed May 28, 2012).
175. Aschengrau, A., and G. R. Seage. 2008. Essentials of epidemiology in public health (2nd ed.). Sudbury, MA: Jones and Bartlett Publishers.
176. Babor, T. F., and R. M. Kadden. 2005. Screening and interventions for alcohol and drug problemsin medical settings: What works? Journal of Trauma 59 (3):S80-S87.
177. Babor, T. F., J. C. Higgens-Biddle, D. Dauser, J. A. Burleson, G. A. Zarkin, and J. Bray. 2006. Brief interventions for at-risk drinking: Patient outcomes and cost-effectiveness in managed care organizations. Alcohol and Alcoholism 41 (6):624-631.
178. Babor, T. F., R. Caetano, S. Casswell, G. Edwards, N. Giesbrecht, K. Graham, J. Grube, L. Hill, H. Holder, R. Homel, M. Livingston, E. Osterberg, J. Rehm, R. Room, and I. Rossow. 2010a. Alcohol: No ordinary commodity: Research and public policy. Oxford: Oxford University Press.
179. Babor, T., J. Caulkins, G. Edwards, B. Fischer, D. Foxcroft, K. Humphreys, I. Obot, J. Rehm, P. Reuter, R. Room, I. Rossow, and J. Strang. 2010b. Drug policy and the public good. Oxford: Oxford University Press.
180. Back, S. E., K. T. Brady, S. C. Sonne, and M. L. Verduin. 2006. Symptom improvement in co-occurring PTSD and alcohol dependence. Journal of Nervous and Mental Disease 194 (9):690-696.
181. Back, S. E., T. Killeen, E. B. Foa, E. J. Santa Ana, D. F. Gros, and K. T. Brady. 2012. Use of an integrated therapy with prolonged exposure to treat PTSD and comorbid alcohol dependence in an Iraq veteran. American Journal of Psychiatry 169 (7):688-691.
182. Baker, D. G., P. Heppner, N. Afari, S. Nunnink, M. Kilmer, A. Simmons, L. Harder, and B. Bosse. 2009. Trauma exposure, branch of service, and physical injury in relation to mental health among US veterans returning from Iraq and Afghanistan. Military Medicine 174 (8):773-778.
183. Ball, J. C., and A. Ross. 1991. The effectiveness of methadone maintenance treatment: Patients, programs, services, and outcome. New York: Springer-Verlag.
184. Bandura, A. 1977. Social learning theory. Englewood Cliffs, NJ: Prentice Hall.
185. Becker, C. B., C. Zayfert, and E. Anderson. 2004. A survey of psychologists' attitudes towards and utilization of exposure therapy for PTSD. Behaviour Research and Therapy 42 (3):277-292.
186. Bellg, A. J., B. Resnick, D. S. Minicucci, G. Ogedegbe, D. Ernst, B. Borrelli, J. Hecht, M. Ory, D. Orwig, and S. Czajkowski. 2004. Enhancing treatment fidelity in health behavior change studies: Best practices and recommendations from the nih behavior change consortium. Health Psychology 23 (5):443-451.
187. Bertholet, N., J.-B. Daeppen, V. Wietlisbach, M. Fleming, and B. Burnand. 2005. Reduction of alcohol consumption by brief alcohol intervention in primary care: Systematic review and meta-analysis. Archives of Internal Medicine 165 (9):986-995.
188. Blatt, S. J., C. A. Sanislow, III, D. C. Zuroff, and P. A. Pilkonis. 1996. Characteristics of effective therapists: Further analyses of data from the National Institute of Mental Health treatment of depression collaborative research program. Journal of Consulting and Clinical Psychology 64 (6):1276-1284.
189. Blume, A. W., and G. A. Marlatt. 2009. The role of executive cognitive functions in changing substance use: What we know and what we need to know. Annals of Behavior Medicine 37 (2):117-125.
190. Botvin, G. J., E. Baker, L. Dusenbury, E. M. Botvin, and T. Diaz. 1995. Long-term follow-up results of a randomized drug abuse prevention trial in a white middle-class population. Journal of the American Medical Association 273 (14):1106-1112.
191. Brady, K., T. Pearlstein, G. M. Asnis, D. Baker, B. Rothbaum, C. R. Sikes, and G. M. Farfel. 2000. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial. Journal of the American Medical Association 283 (14):1837-1844.
192. Brady, K. T., P. Tuerk, S. E. Back, M. E. Saladin, A. E. Waldrop, and H. Myrick. 2009. Combat posttraumatic stress disorder, substance use disorders, and traumatic brain injury. Journal of Addiction Medicine 3 (4):179-188.
193. Brody, G. H., Y. F. Chen, S. R. H. Beach, R. A. Philibert, and S. M. Kogan. 2009. Participation in a family-centered prevention program decreases genetic risk for adolescents' risky behaviors. Pediatrics 124 (3):911-917.
194. Brown, J. M. 2004. The effectiveness of treatment. In The essential handbook of treatment and prevention of alcohol problems, edited by N. Heather and T. Stockwell. London: John Wiley and Sons, Ltd. Pp. 9-20.
195. Brown, R. L., J. J. Patterson, L. A. Rounds, and O. Papasouliotis. 1996. Substance abuse among patients with chronic back pain. Journal of Family Practice 43 (2):152-160.
196. Campbell, J. 2002. Health consequences of intimate partner violence. Lancet 359 (9314):1331-1336.
197. Carroll, K. M. 2005. Recent advances in the psychotherapy of addictive disorders. Current Psychiatry Reports 7 (5):329-336.
198. Carroll, K. M., and L. S. Onken. 2005. Behavioral therapies for drug abuse. American Journal of Psychiatry 162 (8):1452-1460.
199. Carroll, K. M., S. A. Ball, C. Nich, S. Martino, T. L. Frankforter, C. Farentinos, L. E. Kunkel, S. K. Mikulich-Gilbertson, J. Morgenstern, J. L. Obert, D. Polcin, N. Snead, and G. E. Woody. 2006. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study. Drug and Alcohol Dependence 81 (3):301-312.
200. Carroll, K. M., S. Martino, S. A. Ball, C. Nich, T. Frankforter, L. M. Anez, M. Paris, L. Suarez-Morales, J. Szapocznik, W. R. Miller, C. Rosa, J. Matthews, and C. Farentinos. 2009. A multisite randomized effectiveness trial of motivational enhancement therapy for Spanish-speaking substance users. Journal of Consulting and Clinical Psychology 77 (5):993-999.
201. Center for Substance Abuse Treatment. 2006. Substance abuse: Clinical issues in intensive outpatient treatment. Treatment Improvement Protocol (TIP) series 47. Rockville, MD: Substance Abuse and Mental Health Services Administration.
202. Center for Substance Abuse Treatment. 2009. Incorporating alcohol pharmacotherapies into medical practice. Rockville, MD: Substance Abuse and Mental Health Services Administration.
203. Chaloupka, F. J., M. Grossman, and H. Saffer. 2002. The effects of price on alcohol consumption and alcohol-related problems. Alcohol Research & Health 26 (1):22-34.
204. Chaloupka, F. J., A. Yurekli, and G. T. Fong. 2012. Tobacco taxes as a tobacco control strategy. Tobacco Control 21 (2):172-180.
205. Chandra, A. 2011. Views from the homefront: The experiences of youth and spouses from military families. Santa Monica, CA: RAND Corporation.
206. Chartrand, M. M., D. A. Frank, L. F. White, and T. R. Shope. 2008. Effect of parents' wartime deployment on the behavior of young children in military families. Archives of Pediatrics and Adolescent Medicine 162 (11):1009-1014.
207. Chisholm, D., J. Rehm, M. Van Ommeren, and M. Monteiro. 2004. Reducing the global burden of hazardous alcohol use: A comparative cost-effectiveness analysis. Journal of Studies on Alcohol 65 (6):782-793.
208. Coviello, D. M., J. W. Cornish, K. G. Lynch, A. I. Alterman, and C. P. O'Brien. 2010. A randomized trial of oral naltrexone for treating opioid-dependent offenders. American Journal on Addictions 19 (5):422-432.
209. Coviello, D. M., J. W. Cornish, K. G. Lynch, T. Y. Boney, C. A. Clark, J. D. Lee, P. D. Friedmann, E. V. Nunes, T. W. Kinlock, M. S. Gordon, R. P. Schwartz, E. S. Nuwayser, and C. P. O'Brien. 2012. A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers. Substance Abuse 33 (1):48-59.
210. Crits-Christoph, P., and J. Mintz. 1991. Implications of therapist effects for the design and analysis of comparative studies of psychotherapies. Journal of Consulting and Clinical Psychology 59 (1):20-26.
211. Davidson, J. R. T. 2000. Pharmacotherapy of posttraumatic stress disorder: Treatment options, long-term follow-up, and predictors of outcome. Journal of Clinical Psychiatry 61 (Suppl. 5):52-59.
212. Dennis, M., C. K. Scott, and R. Funk. 2003. An experimental evaluation of recovery management checkups (RMC) for people with chronic substance use disorders. Evaluation and Program Planning 26 (3):339-352.
213. Dennis, M. L., C. K. Scott, R. Funk, and M. A. Foss. 2005. The duration and correlates of addiction and treatment careers. Journal of Substance Abuse Treatment 28 (Suppl. 1):S51-S62.
214. Duncan, B. L., S. D. Miller, J. A. Sparks, D. A. Claud, L. R. Reynolds, J. Brown, and L. D. Johnson. 2003. The session rating scale: Preliminary psychometric properties of a "working" alliance measure. Journal of Brief Therapy 3 (1):3-11.
215. Dutra, L., G. Stathopoulou, S. L. Basden, T. M. Leyro, M. B. Powers, and M. W. Otto. 2008. A meta-analytic review of psychosocial interventions for substance use disorders. American Journal of Psychiatry 165 (2):179-187.
216. Edlund, M. J., D. Steffick, T. Hudson, K. M. Harris, and M. Sullivan. 2007. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 129 (3):355-362.
217. Erbes, C., J. Westermeyer, B. Engdahl, and E. Johnsen. 2007. Post-traumatic stress disorder and service utilization in a sample of service members from Iraq and Afghanistan. Military Medicine 172 (4):359-363.
218. Fishbain, D. A., B. Cole, J. Lewis, H. L. Rosomoff, and R. S. Rosomoff. 2008. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidencebased review. Pain Medicine 9 (4):444-459.
219. Foa, E. B., T. M. Keane, M. J. Friedman, and J. Cohen. 2008. Effective treatments for PTSD: Practice guidelines from the International Society for Traumatic Stress Studies (2nd ed.). New York: Guilford Press.
220. Foran, H., A. Smith Slep, and R. Heyman. 2011a. Hazardous alcohol use among active duty Air Force personnel: Identifying unique risk and promotive factors. Psychology of Addictive Behaviors 25 (1):28-40.
221. Foran, H. M., R. E. Heyman, and A. M. S. Slep. 2011b. Hazardous drinking and military community functioning: Identifying mediating risk factors. Journal of Consulting & Clinical Psychology 79 (4):521-532.
222. Gibbs, D. A., S. L. Martin, L. L. Kupper, and R. E. Johnson. 2007. Child maltreatment in enlisted soldiers' families during combat-related deployments. Journal of the American Medical Association 298 (5):528-535.
223. Graham, K. 2000. Preventive interventions for on-premise drinking: A promising but underresearched area of prevention. Contemporary Drug Problems 27 (3):593-668.
224. Graham, K., and R. Homel. 2008. Raising the bar: Preventing aggression in and around bars, clubs and pubs. Abingdon, UK: Willan Publishing.
225. Graham, K., S. Bernards, D. W. Osgood, R. Homel, and J. Purcell. 2005. Guardians and handlers: The role of bar staff in preventing and managing aggression. Addiction 100 (6):755-766.
226. Gray, B. T. 2001. A factor analytic study of the Substance Abuse Subtle Screening Inventory (SASSI). Educational and Psychological Measurement 61 (1):102-118.
227. Hansen, W. B., and J. W. Graham. 1991. Preventing alcohol, marijuana, and cigarette use among adolescents: Peer pressure resistance training versus establishing conservative norms. Preventive Medicine 20 (3):414-430.
228. Hawkins, J. D., R. F. Catalano, and J. Y. Miller. 1992. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: Implications for substance abuse prevention. Psychological Bulletin 112 (1):64-105.
229. Hennekens, C. H., J. E. Buring, and S. L. Mayrent. 1987. Epidemiology in medicine (1st ed.). Philadelphia, PA: Lippincott Williams and Wilkins.
230. Hien, D. A., A. N. C. Campbell, L. M. Ruglass, M. C. Hu, and T. Killeen. 2010. The role of alcohol misuse in PTSD outcomes for women in community treatment: A secondary analysis of NIDA's Women and Trauma Study. Drug and Alcohol Dependence 111 (1-2):114-119.
231. Holder, H. D., P. J. Gruenewald, W. R. Ponicki, A. J. Treno, J. W. Grube, R. F. Saltz, R. B. Voas, R. Reynolds, J. Davis, L. Sanchez, G. Gaumont, and P. Roeper. 2000. Effect of community-based interventions on high-risk drinking and alcohol-related injuries. Journal of the American Medical Association 284 (18):2341-2347.
232. Horwitz, A. V., C. S. Widom, J. McLaughlin, and H. R. White. 2001. The impact of childhood abuse and neglect on adult mental health: A prospective study. Journal of Health and Social Behavior 42 (2):184-201.
233. Hughes, C. E., and A. Stevens. 2010. What can we learn from the Portuguese decriminalization of illicit drugs? British Journal of Criminology 50 (6):999-1022.
234. Hussey, J. M., J. J. Chang, and J. B. Kotch. 2006. Child maltreatment in the United States: Prevalence, risk factors, and adolescent health consequences. Pediatrics 118 (3):933-942.
235. Imel, Z. E., B. E. Wampold, S. D. Miller, and R. R. Fleming. 2008. Distinction without a difference:Direct comparisons of psychotherapies for alcohol use disorders. Psychology of Addictive Behaviors 22 (4):533-543.
236. IOM (Institute of Medicine). 1994a. Reducing risks for mental disorders: Frontiers for preventive intervention research. Washington, DC: National Academy Press.
237. IOM. 1994b. Under the influence? Drugs and the American work force: Summary: Conclusion and recommendations. Washington, DC: National Academy Press.
238. IOM. 1995. Federal regulation of methadone treatment. Washington, DC: National Academy Press.
239. IOM. 2000. To err is human: Building a safer health system. Washington, DC: National Academy Press.
240. IOM. 2001. Crossing the quality chasm: A new health system for the 21st century. Washington, DC: National Academy Press.
241. IOM. 2006. Improving the quality of health care for mental and substance-use conditions: Quality chasm series. Washington, DC: The National Academies Press.
242. IOM. 2007. Treatment of PTSD: An assessment of the evidence. Washington, DC: The National Academies Press.
243. Jacobsen, L. K., S. M. Southwick, and T. R. Kosten. 2001. Substance use disorders in patients with posttraumatic stress disorder: A review of the literature. American Journal of Psychiatry 158 (8):1184-1190.
244. Jacobson, I. G., M. A. K. Ryan, T. I. Hooper, T. C. Smith, P. J. Amoroso, E. J. Boyko, G. D. Gackstetter, T. S. Wells, and N. S. Bell. 2008. Alcohol use and alcohol-related problems before and after military combat deployment. Journal of the American Medical Association 300 (6):663-675.
245. Jakupcak, M., M. T. Tull, M. J. McDermott, D. Kaysen, S. Hunt, and T. Simpson. 2010. PTSD symptom clusters in relationship to alcohol misuse among Iraq and Afghanistan war veterans seeking post-deployment VA health care. Addictive Behaviors 35 (9):840-843.
246. Kalivas, P. W., and N. D. Volkow. 2005. The neural basis of addiction: A pathology of motivation and choice. American Journal of Psychiatry 162 (8):1403-1413.
247. Kaner, E. F. S., H. O. Dickinson, F. R. Beyer, F. Campbell, C. Schlesinger, N. Heather, J. B. Saunders, B. Burnand, and E. D. Pienaar. 2009. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database of Systematic Reviews 1.
248. Karoly, L. A., P. W. Greenwood, S. S. Everingham, J. Hoube, M. R. Kilburn, C. P. Rydell, M. Sanders, and J. Chiesa. 1998. Investing in our children: What we know and don't know about the costs and benefits of early childhood interventions. Santa Monica, CA: RAND Corporation.
249. Karoly, L. A., M. R. Kilburn, J. H. Bigelow, J. P. Caulkins, and J. S. Cannon. 2001. Assessing costs and benefits of early childhood intervention programs: Overview and application to the starting early starting smart program. Seattle, WA: Casey Family Programs and Santa Monica, CA: RAND Corporation.
250. Kessler, R. C., A. Sonnega, E. Bromet, M. Hughes, and C. B. Nelson. 1995. Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry 52 (12):1048-1060.
251. Kivlighan, D. M., Jr., and D. M. Kivlighan, III. 2009. Training related changes in the ways that group trainees structure their knowledge of group counseling leader interventions. Group Dynamics 13 (3):190-204.
252. Knapp, W. P., B. Soares, M. Farrel, and M. S. Lima. 2007. Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database of Systematic Reviews 3.
253. Kosten, T. R., and P. G. O'Connor. 2003. Management of drug and alcohol withdrawal. New England Journal of Medicine 348 (18):1786-1795.
254. Krystal, J. H., J. A. Cramer, W. F. Krol, G. F. Kirk, and R. A. Rosenheck. 2001. Naltrexone in the treatment of alcohol dependence. New England Journal of Medicine 345 (24):1734-1739.
255. Kumpfer, K. L., R. Alvarado, and H. O. Whiteside. 2003. Family-based interventions for substance use and misuse prevention. Substance Use and Misuse 38 (11-13):1759-1787, 1916.
256. Lambert, M. J. 2005. Early response in psychotherapy: Further evidence for the importance of common factors rather than "placebo effects." Journal of Clinical Psychology 61 (7):855-869.
257. Larson, M. J., N. R. Wooten, R. S. Adams, and E. L. Merrick. 2012. Military combat deployments and substance use: Review and future directions. Journal of Social Work Practice in the Addictions 12 (1):6-27.
258. Lester, P., K. Peterson, J. Reeves, L. Knauss, D. Glover, C. Mogil, N. Duan, W. Saltzman, R. Pynoos, K. Wilt, and W. Beardslee. 2010. The long war and parental combat deployment: Effects on military children and at-home spouses. Journal of the American Academy of Child and Adolescent Psychiatry 49 (4):310-320.
259. Ling, W., L. Amass, S. Shoptaw, J. J. Annon, M. Hillhouse, D. Babcock, G. Brigham, J. Harrer, M. Reid, J. Muir, B. Buchan, D. Orr, G. Woody, J. Krejci, and D. Ziedonis. 2005. A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction 100 (8):1090-1100.
260. Lowinson, J. H., ed. 2005. Substance abuse: A comprehensive textbook. Philadelphia, PA: Lippincott Williams & Wilkins.
261. Luborsky, L., A. T. McLellan, L. Diguer, G. Woody, and D. A. Seligman. 1997. The psychotherapist matters: Comparison of outcomes across twenty-two therapists and seven patient samples. Clinical Psychology: Science and Practice 4 (1):53-65.
262. Mallinckrodt, B., and M. L. Nelson. 1991. Counselor training level and the formation of the psychotherapeutic working alliance. Journal of Counseling Psychology 38 (2):133-138.
263. Manchikanti, L., K. S. Damron, C. D. McManus, and R. C. Barnhill. 2004. Patterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: A prospective, observational study. Pain Physician 7 (4):431-437.
264. Mansfield, A. J., and C. C. Engel. 2011. Understanding substance use in military spouses. Journal of Clinical Psychology in Medical Settings 18 (2):198-199.
265. Marshall, R. D., K. L. Beebe, M. Oldham, and R. Zaninelli. 2001. Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo-controlled study. American Journal of Psychiatry 158 (12):1982-1988.
266. Martell, B. A., P. G. O'Connor, R. D. Kerns, W. C. Becker, K. H. Morales, T. R. Kosten, and D. A. Fiellin. 2007. Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Annals of Internal Medicine 146 (2):116-127.
267. Mattick, R. P., J. Kimber, C. Breen, and M. Davoli. 2008. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews (Online) 2.
268. Mattick, R. P., C. Breen, J. Kimber, and M. Davoli. 2009. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 3.
269. Mayes, L. C., and N. Suchman. 2006. Developmental pathways to substance abuse. In Developmental psychopathology: Risk, disorder, and adaptation (Vol. 3), edited by D. Cicchetti and D. Cohen. New York: Wiley. Pp. 599-619.
270. Mayfield, W. A., C. M. Kardash, and D. M. Kivlighan, Jr. 1999. Differences in experienced and novice counselors' knowledge structures about clients: Implications for case conceptualization. Journal of Counseling Psychology 46 (4):504-514.
271. McCarty, D., K. J. McConnell, and L. A. Schmidt. 2010. Priorities for policy research on treatments for alcohol and drug use disorders. Journal of Substance Abuse Treatment 39 (2):87-95.
272. McGlynn, E. A., S. M. Asch, J. Adams, J. Keesey, J. Hicks, A. DeCristofaro, and E. A. Kerr. 2003. The quality of health care delivered to adults in the United States. New England Journal of Medicine 348 (26):2635-2645.
273. McKay, J. R., K. G. Lynch, D. S. Shepard, and H. M. Pettinati. 2005. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes. Archives of General Psychiatry 62 (2):199-207.
274. McLellan, A. T. 2002. Have we evaluated addiction treatment correctly? Implications from a chronic care perspective. Addiction 97 (3):249-252.
275. McLellan, A. T., D. C. Lewis, C. P. O'Brien, and H. D. Kleber. 2000. Drug dependence, a chronic medical illness. Journal of the American Medical Association 284 (13):1689-1695.
276. McLellan, A. T., G. S. Skipper, M. Campbell, and R. L. DuPont. 2008. Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States. British Medical Journal 337 (7679):1154-1156.
277. Mee-Lee, D. 2001. ASAM patient placement criteria for the treatment of substance-related disorders. (2nd rev. ed.). Chevy Chase, MD: American Society of Addiction Medicine.
278. Mee-Lee, D., and G. D. Shulman. 2003. The ASAM placement criteria and matching patients to treatment. In Principles of addiction medicine (3rd ed.), edited by A. W. Graham, T. K. Schultz, M. F. Mayo-Smith, R. K. Ries, and B. B. Wilford. Chevy Chase, MD: American Society of Addiction Medicine. Pp. 453-465.
279. Mertens, J. R., C. Weisner, G. T. Ray, B. Fireman, and K. Walsh. 2005. Hazardous drinkers and drug users in HMO primary care: Prevalence, medical conditions, and costs. Alcoholism: Clinical and Experimental Research 29 (6):989-998.
280. MHAT (Mental Health Advisory Team). 2006. Mental Health Advisory Team (MHAT) IV, Operation Iraqi Freedom 05-07. Washington, DC: Office of the Surgeon, Multinational Force-Iraq and Office of the Surgeon General, United States Army Medical Command.
281. Mihalik, S., A. Fagan, K. Irwin, D. Ballard, and D. Elliot. 2004. Blueprints for violence prevention. Boulder, CO: Center for the Study and Prevention of Violence.
282. Miller, S. D., B. L. Duncan, J. Brown, J. A. Sparks, and D. A. Claud. 2003. The outcome rating scale: A preliminary study of the reliability, validity, and feasibility of a brief visual analog measure. Journal of Brief Therapy 2 (2):91-100.
283. Miller, S. D., D. Mee-Lee, W. Plum, and M. A. Hubble. 2005. Making treatment count: Clientdirected outcome-informed clinical work with problem drinkers. In Handbook of clinical family therapy, edited by J. Lebow. Hoboken, NJ: John Wiley & Sons. Pp. 281-308.
284. Miller, W. R., and P. L. Wilbourne. 2002. Mesa grande: A methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction 97 (3):265-277.
285. Miller, W. R., J. L. Sorensen, J. A. Selzer, and G. S. Brigham. 2006. Disseminating evidencebased practices in substance abuse treatment: A review with suggestions. Journal of Substance Abuse Treatment 31 (1):25-39.
286. Montgomery, L., A. K. Burlew, A. S. Kosinski, and A. A. Forcehimes. 2011. Motivational enhancement therapy for African American substance users: A randomized clinical trial. Cultural Diversity and Ethnic Minority Psychology 17 (4):357-365.
287. Moos, R. H. 2007. Theory-based active ingredients of effective treatments for substance use disorders. Drug and Alcohol Dependence 88 (2-3):109-121.
288. Morgenstern, J., and J. R. McKay. 2007. Rethinking the paradigms that inform behavioral treatment research for substance use disorders. Addiction 102 (9):1377-1389.
289. Morrissey, J. P., E. W. Jackson, A. R. Ellis, H. Amaro, V. B. Brown, and L. M. Najavits. 2005. Twelve-month outcomes of trauma-informed interventions for women with co-occurring disorders. Psychiatric Services 56 (10):1213-1222.
290. Muir Gray, J. A. 2004. New concepts in screening. British Journal of General Practice 54 (501):292-298.
291. Najavits, L. M., D. Ryngala, S. E. Back, E. Bolton, K. T. Mueser, and K. T. Brady. 2008. Treatment for PTSD and comorbid disorders: A review of the literature. In Effective treatments for PTSD: Practice guidelines from the International Society for Traumatic Stress Studies (2nd ed.), edited by E. B. Foa, T. M. Keane, M. J. Friedman, and J. Cohen. New York: Guilford Press. Pp. 508-535.
292. National Highway Traffic Safety Administration. 2009. Traffic Safety Facts 2009: A Compilation of Motor Vehicle Crash Data from the Fatality Analysis Reporting System and the General Estimates System, Early Edition. Washington, DC: U.S. Department of Transportation.
293. NIAAA (National Institute on Alcohol Abuse and Alcoholism). 2005. Helping patients who drink too much: A clinician's guide. Bethesda, MD: NIAAA.
294. NIDA (National Institute on Drug Abuse). 2009a. Principles of drug addiction treatments. NIH Publication Number: 09-4180. Bethesda, MD: NIDA. itute on Alcohol Abuse and Alcoholism).
295. NIDA. 2009b. Review of the prevention research portfolio. Bethesda, MD: NIDA.
296. NRC (National Research Council) and IOM. 2000. From neurons to neighborhoods: The science of early childhood development. Washington, DC: National Academy Press.
297. NRC and IOM. 2009. Preventing mental, emotional, and behavioral disorders among young people: Progress and possibilities. Washington, DC: The National Academies Press.
298. Ockene, J. K., A. Adams, T. G. Hurley, E. V. Wheeler, and J. R. Hebert. 1999. Brief physician- and nurse practitioner-delivered counseling for high-risk drinkers: Does it work? Archives of Internal Medicine 159 (18):2198-2205.
299. ONDCP (Office of National Drug Control Policy). 2001. Evidence-based principles for substance abuse prevention. Washington, DC: ONDCP. https://www.ncjrs.gov/ondcppubs/ publications/prevent/evidence:based_eng.html (accessed August 6, 2012).
300. ONDCP. 2011a. Epidemic: Responding to America's prescription drug abuse crisis. Washington, DC: ONDCP.
301. ONDCP. 2011b. National drug control strategy, 2011. Washington, DC: ONDCP.
302. ONDCP. 2012. Prescription drug abuse. Washington, DC: ONDCP. http://www.whitehouse. gov/ondcp/prescription-drug-abuse (accessed August 7, 2012).
303. Ouimette, P., and P. J. Brown. 2002. Trauma and substance abuse: Causes, consequences, and treatment of comorbid disorders. Washington, DC: American Psychological Association Press.
304. Peirce, J. M., N. M. Petry, M. L. Stitzer, J. Blaine, S. Kellogg, F. Satterfield, M. Schwartz, J. Krasnansky, E. Pencer, L. Silva-Vazquez, K. C. Kirby, C. Royer-Malvestuto, J. M. Roll, A. Cohen, M. L. Copersino, K. Kolodner, and R. Li. 2006. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: A national drug abuse treatment clinical trials network study. Archives of General Psychiatry 63 (2):201-208.
305. Perry, C. L., K.-I. Klepp, A. Halper, K. G. Hawkins, and D. M. Murray. 1986. A process evaluation study of peer leaders in health education. Journal of School Health 56 (2):62-67.
306. Petrakis, I. L., J. Poling, C. Levinson, C. Nich, K. Carroll, E. Ralevski, and B. Rounsaville. 2006. Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder. Biological Psychiatry 60 (7):777-783.
307. Petry, N. M., S. M. Alessi, J. Marx, M. Austin, and M. Tardif. 2005. Vouchers versus prizes: Contingency management treatment of substance abusers in community settings. Journal of Consulting and Clinical Psychology 73 (6):1005-1014.
308. Powers, M. B., E. Vedel, and P. M. G. Emmelkamp. 2008. Behavioral couples therapy (BCT) for alcohol and drug use disorders: A meta-analysis. Clinical Psychology Review 28 (6):952-962.
309. Rammohan, V., R. A. Hahn, R. Elder, R. Brewer, J. Fielding, T. S. Naimi, T. L. Toomey, and S. K. Chattopadhyay. 2011. Effects of dram shop liability and enhanced overservice law enforcement initiatives on excessive alcohol consumption and related harms: Two community guide systematic reviews. American Journal of Preventive Medicine 41 (3):334-343.
310. Reiff-Hekking, S., J. K. Ockene, T. G. Hurley, and G. W. Reed. 2005. Brief physician and nurse practitioner-delivered counseling for high-risk drinking. Results at 12-month follow-up. Journal of General Internal Medicine 20 (1):7-13.
311. Robertson, E. B., S. L. David, and S. A. Rao. 2003. Preventing drug use among children and adolescents: A research-based guide for parents, educators, and community leaders (2nd ed.). Rockville, MD: NIDA.
312. Rösner, S. 2011. Review: Acamprosate increases abstinence in patients with alcohol dependence.Annals of Internal Medicine 154 (2):JC1-10.
313. Rösner, S., A. Hackl-Herrwerth, S. Leucht, P. Lehert, S. Vecchi, and M. Soyka. 2010a. Acamprosate for alcohol dependence. Cochrane Database of Systematic Reviews (Online) 9.
314. Rösner, S., A. Hackl-Herrwerth, S. Leucht, S. Vecchi, M. Srisurapanont, and M. Soyka. 2010b. Opioid antagonists for alcohol dependence. Cochrane Database of Systematic Reviews 12.
315. Rowe, C. L. 2012. Family therapy for drug abuse: Review and updates 2003-2010. Journal of Marital and Family Therapy 38 (1):59-81.
316. Rowe, C. L., and H. A. Liddle. 2003. Substance abuse. Journal of Marital and Family Therapy 29 (1):97-120.
317. Rutter, M. 2006. Implications of resilience concepts for scientific understanding. Annals of the New York Academy of Sciences 1094:1-12.
318. Saltz, R. F., M. J. Paschall, R. P. McGaffigan, and P. M. Nygaard. 2010. Alcohol risk management in college settings: The safer California universities randomized trial. American Journal of Preventive Medicine 39 (6):491-499.
319. SAMHSA (Substance Abuse and Mental Health Services Administration). 2010. Results from the 2009 National Survey on Drug Use and Health: Mental health findings. NSDUH Series H-39. Rockville, MD: Office of Applied Studies.
320. SAMHSA. 2012. NREPP's quality of research. http://www.nrepp.samhsa.gov/ReviewQOR. aspx (accessed May 28, 2012).
321. Scott, C. K., M. L. Dennis, and M. A. Foss. 2005. Utilizing recovery management checkups to shorten the cycle of relapse, treatment reentry, and recovery. Drug & Alcohol Dependence 78 (3):325-338.
322. Seal, K. H., D. Bertenthal, C. R. Miner, S. Sen, and C. Marmar. 2007. Bringing the war back home mental health disorders among 103, 788 US veterans returning from Iraq and Afghanistan seen at Department of Veterans Affairs facilities. Archives of International Medicine 167 (5):476-482.
323. Seal, K. H., T. J. Metzler, K. S. Gima, D. Bertenthal, S. Maguen, and C. R. Marmar. 2009. Trends and risk factors for mental health diagnoses among Iraq and Afghanistan veterans using Department of Veterans Affairs health care, 2002-2008. American Journal of Public Health 99 (9):1651-1658.
324. Seal, K. H., G. Cohen, A. Waldrop, B. E. Cohen, S. Maguen, and L. Ren. 2011. Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001-2010: Implications for screening, diagnosis and treatment. Drug and Alcohol Dependence 116 (1-3):93-101.
325. Shen, Y.-C., J. Arkes, and T. V. Williams. 2012. Effects of Iraq/Afghanistan deployments on major depression and substance use disorder: Analysis of active duty personnel in the US military. American Journal of Public Health 102 (S1):S80-S87.
326. Shonkoff, J. P., L. Richter, J. van der Gaag, and Z. A. Bhutta. 2012. An integrated scientific framework for child survival and early childhood development. Pediatrics 129 (2):e460-e472.
327. Simpson, D. D., G. W. Joe, G. A. Rowan-Szal, and J. M. Greener. 1997. Drug abuse treatment process components that improve retention. Journal of Substance Abuse Treatment 14 (6):565-572.
328. Smedslund, G., R. C. Berg, K. T. Hammerstrøm, A. Steiro, K. A. Leiknes, H. M. Dahl, and K. Karlsen. 2011. Motivational interviewing for substance abuse. Cochrane Database of Systematic Reviews 5.
329. Spera, C., and K. Franklin. 2010. Reducing drinking among junior enlisted Air Force members in five communities: Early findings of the EUDL program's influence on self-reported drinking behaviors. Journal of Studies on Alcohol and Drugs 71 (3):373-383.
330. Spoth, R. L., L. M. Schainker, and S. HillerSturmhöefel. 2011. Translating family-focused prevention science into public health impact: Illustrations from partnership-based research. Alcohol Research and Health 34 (2):188-203.
331. Srisurapanont, M., and N. Jarusuraisin. 2005. Opioid antagonists for alcohol dependence. Cochrane Database of Systematic Reviews 1.
332. Sternberg, K. J., L. P. Baradaran, C. B. Abbott, M. E. Lamb, and E. Guterman. 2006. Type of violence, age, and gender differences in the effects of family violence on children's behavior problems: A mega-analysis. Developmental Review 26 (1):89-112.
333. Stine, S. M., M. K. Greenwald, and T. R. Kosten. 2004. Pharmacologic interventions for opioid addiction. In Principles of addiction medicine (3rd ed.), edited by S. T. Graham, M. Mayo-Smith, R. K. Ries, and B. B. Wilford. Chevy Chase, MD: American Society of Addiction Medicine. Pp. 735-748.
334. Stockwell, T., and P.J. Gruenewald. 2004. Controls on the physical availability of alcohol. In The essential handbook of treatment and prevention of alcohol problems, edited by N. Heather and T. Stockwell. Chichester, UK: Wiley and Sons. Pp. 213-233.
335. Tanielian, T. L., L. Jaycox, T. L. Schell, G. N. Marshall, M. A. Burnam, C. Eibner, B. R. Karney, L. S. Meredith, J. S. Ringel, and M. E. Vaiana. 2008. Invisible wounds of war: Summary and recommendations for addressing psychological and cognitive injuries. Santa Monica, CA: RAND Corporation, Center for Military Health Policy Research.
336. Treatment Research Institute. 2010. Integrating appropriate services for substance use conditions in health care settings: An issue brief on lessons learned and challenges ahead. Philadelphia, PA: Forum on Integration, Treatment Research Institute.
337. Treno, A. J., P. J. Gruenewald, J. P. Lee, and L. G. Remer. 2007. The sacramento neighborhood alcohol prevention project: Outcomes from a community prevention trial. Journal of Studies on Alcohol and Drugs 68 (2):197-207.
338. Trickett, P. K., J. G. Noll, and F. W. Putnam. 2011. The impact of sexual abuse on female development:Lessons from a multigenerational, longitudinal research study. Development and Psychopathology 23 (02):453-476.
339. Tucker, P., R. Zaninelli, R. Yehuda, L. Ruggiero, K. Dillingham, and C. D. Pitts. 2001. Paroxetine in the treatment of chronic posttraumatic stress disorder: Results of a placebocontrolled, flexible-dosage trial. Journal of Clinical Psychiatry 62 (11):860-868.
340. VA (Department of Veterans Affairs) and DoD (Department of Defense). 2009. VA/DoD clinical practice guideline for management of substance use disorders. Washington, DC: VA and DoD.
341. Valente, T. W. 2010. Social networks and health: Models, methods, and applications. Oxford, UK: Oxford University Press.
342. VHA (Veterans Health Administration) Office of Public Health and Environmental Hazards. 2008. Analysis of VA health care utilization among US Global War on Terrorism (GWOT) veterans: Operation Enduring Freedom/Operation Iraqi Freedom. Washington, DC: VHA.
343. Wagenaar, A. C., and T. L. Toomey. 2002. Effects of minimum drinking age laws: Review and analyses of the literature from 1960 to 2000. Journal of Studies on Alcohol 14 (Suppl.):206-225.
344. Wagenaar, A. C., M. J. Salois, and K. A. Komro. 2009. Effects of beverage alcohol price and tax levels on drinking: A meta-analysis of 1003 estimates from 112 studies. Addiction 104 (2):179-190.
345. Weisner, C., and H. Matzger. 2002. A prospective study of the factors influencing entry to alcohol and drug treatment. Journal of Behavioral Health Services and Research 29 (2):126-137.
346. Weiss, R. D., J. S. Potter, D. A. Fiellin, M. Byrne, H. S. Connery, W. Dickinson, J. Gardin, M. L. Griffin, M. N. Gourevitch, D. L. Haller, A. L. Hasson, Z. Huang, P. Jacobs, A. S. Kosinski, R. Lindblad, E. F. McCance-Katz, S. E. Provost, J. Selzer, E. C. Somoza, S. C. Sonne, and W. Ling. 2011. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Archives of General Psychiatry 68 (12):1238-1246.
347. WHO (World Health Organization). 2009. Global health risks: Mortality and burden of disease attributable to selected major risks. Geneva, Switzerland: World Health Organization.
348. Wilk, J. E., P. D. Bliese, P.Y. Kim, J.L. Thomas, D. McGurk, and C.W. Hoge. 2010. Relationship of combat experiences to alcohol misuse among U.S. soldiers returning from the Iraq war. Drug and Alcohol Dependence 108 (1-2):115-121.
349. Wills, T. A., and R. Vaughan. 1989. Social support and substance use in early adolescence. Journal of Behavioral Medicine 12 (4):321-339.
350. Wilson, J. M. G., and G. Jungner. 1968. Principles and practice of screening for disease. Geneva, Switzerland: World Health Organization.
351. Woody, G. E., S. A. Poole, G. Subramaniam, K. Dugosh, M. Bogenschutz, P. Abbott, A. Patkar, M. Publicker, K. McCain, J. S. Potter, R. Forman, V. Vetter, L. McNicholas, J. Blaine, K. G. Lynch, and P. Fudala. 2008. Extended vs. short-term buprenorphine-naloxone for treatment of opioid-addicted youth a randomized trial. Journal of the American Medical Association 300 (17):2003-2011.
352. APA (American Psychiatric Association). 2000. Diagnostic and statistical manual of mental disorders, fourth edition, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
353. Babor, T. F., B. G. McRee, P. A. Kassebaum, P. L. Grimaldi, K. Ahmed, and J. Bray. 2007. Screening, Brief Intervention, and Referral to Treatment (SBIRT): Toward a public health approach to the management of substance abuse. Substance Abuse 28 (3):7-30.
354. Berwick, D. M. 2002. A user's manual for the IOM's "quality chasm" report. Health Affairs 21 (3):80-90.
355. Chou, R., G. J. Fanciullo, P. G. Fine, J. A. Adler, J. C. Ballantyne, P. Davies, M. I. Donovan, D. A. Fishbain, K. M. Foley, J. Fudin, A. M. Gilson, A. Kelter, A. Mauskop, P. G. O'Connor, S. D. Passik, G. W. Pasternak, R. K. Portenoy, B. A. Rich, R. G. Roberts, K. H. Todd, and C. Miaskowski. 2009. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. Journal of Pain 10 (2):113-130.
356. Compton, W. M., and N. D. Volkow. 2006. Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug and Alcohol Dependence 81 (2):103-107.
357. Crano, W. D., and M. Burgoon. 2002. Mass media and drug prevention: Classic and contemporarytheories and research. Mahwah, NJ: Lawrence Erlbaum Associates.
358. DCoE (Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury) 2011. DCoE pilot project evaluation report A401: Fort Hood Intensive Outpatient Program (IOP). Arlington, VA: DCoE.
359. DCoE. 2012. The real warriors campaign. http://www.realwarriors.net/aboutus (accessed. May 29, 2012).
360. Defense Health Board. 2011. Psychotropic medication prescription practices and use and complementary and alternative medicine use. Falls Church, VA: Defense Health Board.
361. DoD (Department of Defense). 1985. Instruction 1010.6: Rehabilitation and referral services for alcohol and drug abusers. Washington, DC: DoD.
362. DoD. 1994. Directive 1010.1: Health promotion. Washington, DC: DoD.
363. DoD. 1997. Directive 1010.4: Drug and alcohol abuse by DoD personnel. Washington, DC: DoD.
364. DoD. 2011a. Instruction 6490.08: Command notification requirements to dispel stigma in providing mental health care to service members. Washington, DC: DoD.
365. DoD. 2011b. Comprehensive plan on prevention, diagnosis, and treatment of substance use disorders and disposition of substance use offenders in the armed forces. Washington, DC: Office of the Under Secretary of Defense.
366. DoD. 2012. The Department of Defense pharmacoeconomic center. http://www.pec.ha.osdmil/ (accessed August 07, 2012).
367. Forgatch, M. S., and G. R. Patterson. 2010. Parent management training-Oregon model: An intervention for antisocial behavior in children and adolescents. In Evidence-based psychotherapies for children and adolescents (2nd ed.), edited by J. R. Weisz and A. E. Kazdin. New York: Guilford Press. Pp. 159-178.
368. GAO (Government Accountability Office). 2011. Prescription drug control: DEA has enhanced efforts to combat diversion, but could better assess and report program results Washington, DC: GAO.
369. Gewirtz, A. H., C. R. Erbes, M. A. Polusny, M. S. Forgatch, and D. S. DeGarmo. 2011. Helping military families through the deployment process: Strategies to support parenting Professional Psychology: Research and Practice 42(1):56-62.
370. Hawkins, J. D., and R. F. J. Catalano. 1992. Communities that care. San Francisco, CA: Jossey-Bass.
371. Heyman, R. E., and A. M. Smith Slep. 2001. Risk factors for family violence: Special issue. Aggression and Violent Behavior 6 (2-3):115-356.
372. Heyman, R. E., A. M. Smith Slep, and J. P. Nelson. 2011. Empirically guided community intervention for partner abuse, child maltreatment, suicidality, and substance misuse. In Risk and resilience in U.S. military families, edited by S. M. M. Wadsworth and D. Riggs New York: Springer. Pp. 85-110.
373. Humphreys, J., J. Y. Tsoh, M. A. Kohn, and B. Gerbert. 2011. Increasing discussions of intimate partner violence in prenatal care using Video Doctor plus provider cueing: A randomized, controlled trial. Women's Health Issues 21 (2):136-144.
374. Jackson, R. A., N. E. Stotland, A. B. Caughey, and B. Gerbert. 2011. Improving diet and exercise in pregnancy with Video Doctor counseling: A randomized trial. Patient Education and Counseling 83 (2):203-209.
375. Kosten, T. R., and K. McQueen. 2008. General approaches to substance and polydrug use disorders. In Psychiatry, edited by A. Tasman, J. Kay, and J. R. Lieberman. London England: John Wiley & Sons. Pp. 922-935.
376. O'Connor, E. A., E. P. Whitlock, B. Gaynes, and T. L. Beil. 2009. Screening for depression in adults and older adults in primary care: An updated systematic review. http://www.ncbi.nlm.nih.gov/pubmed/20722174 (accessed June 14, 2012).
377. Office of National Drug Control Policy. 2001. Evidence-based principles for substance abuse prevention. Washington, DC: Office of National Drug Control Policy.
378. Office of National Drug Control Policy. 2011. Epidemic: Responding to America's prescription drug abuse crisis. Washington, DC: Office of National Drug Control Policy.
379. Pentz, M. A. 2003. Evidence-based prevention: Characteristics, impact, and future direction. Journal of Psychoactive Drugs 35 (Suppl.):143-152.
380. Riggs, N. R., C. P. Chou, and M. A. Pentz. 2009. Preventing growth in amphetamine use: Long-term effects of the Midwestern Prevention Project (MPP) from early adolescence to early adulthood. Addiction 104 (10):1691-1699.
381. Runyan, C. N., V. P. Fonseca, and C. Hunter. 2003. Integrating consultative behavioral healthcare into the Air Force medical system. In Behavioral health as primary care: Beyond efficacy to effectiveness, edited by W. T. O'Donohue, K. E. Ferguson, and N. A. Cummings. Reno, NV: Context Press. Pp. 145-163.
382. SAIC (Science Applications International Corporation). 2010. Department of Defense awards adolescent substance abuse counseling services contract to SAIC. http://www.militarymentalhealth.org/ (accessed August 8, 2012).
383. Screening for Mental Health, Inc. 2012. Military Mental Health Screening Program. http://www.militarymentalhealth.org (accessed August 3, 2012).
384. Seligman, M. E. P. 1998. Learned optimism. New York: Pocket Books (Simon and Schuster).
385. Spera, C., and K. Franklin. 2010. Reducing drinking among junior enlisted Air Force members in five communities: Early findings of the EUDL program's influence on self-reported drinking behaviors. Journal of Studies on Alcohol and Drugs 71 (3):373-383.
386. Spera, C., F. Barlas, R. Z. Szoc, J. Prabhakaran, and M. H. Cambridge. 2012. Examining the influence of the Enforcing Underage Drinking Laws (EUDL) program on alcoholrelated outcomes in five communities surrounding Air Force bases. Addictive Behaviors 37 (4):513-516.
387. Tsoh, J. Y., M. A. Kohn, and B. Gerbert. 2010. Promoting smoking cessation in pregnancy with Video Doctor plus provider cueing: A randomized trial. Acta Obstetricia et Gynecologica Scandinavica 89 (4):515-523.
388. U.S. Air Force. 2011. Instruction 44-121: Alcohol and Drug Abuse Prevention and Treatment (ADAPT) program. Washington, DC: Department of the Air Force.
389. U.S. Army. 2009. Army regulation 600-85: The Army substance abuse program. http://www.apd.army.mil/pdffiles/r600_85.pdf (accessed October 11, 2011).
390. U.S. Army. 2010. Pain Management Task Force final report. Washington, DC: Office of the Army Surgeon General.
391. U.S. Army. 2011a. ALARACT 062/2011: Changes to length of authorized duration of controlled substance prescriptions in MEDCOM regulation 40-51. Washington, DC: Office of the Army Surgeon General.
392. U.S. Army. 2011b. ASAC standard operating procedures (revised). Cedar Rapids, IA: Area Substance Abuse Council.
393. U.S. Army. 2012. Policy Guidance on the assessment and treatment of post-traumatic stress disorder (PTSD). Fort Sam Houston, TX: Department of the Army.
394. U.S. Marine Corps. 2011. Order 5300.17: Marine Corps substance abuse program. Washington, DC: Department of the Navy.
395. U.S. Navy. 1990. BUMED Instruction 5353.3: Use of disulfiram (Antabuse). Washington, DC: Department of the Navy.
396. U.S. Navy. 1999. BUMEDINST 5353.4A: Standards for provision of substance related disorder treatment services. Washington, DC: Bureau of Medicine, Department of the Navy.
397. U.S. Navy. 2009. Operation Navy Instruction 5350.4D: Navy alcohol and drug abuse prevention and control. Washington, DC: Department of the Navy.
398. U.S. Navy. 2011. SECNAVINST 5300.28E: Military substance abuse prevention and control Washington, DC: Department of the Navy.
399. U.S. Navy. 2012a. NAVADMIN 082/12: Implementation of urinalysis testing for synthetic compounds. Washington, DC: Department of the Navy.
400. U.S. Navy. 2012b. 21st century sailor and marine. http://www.21stcentury.navy.mil/faqs.aspx. (accessed June 4, 2012).
401. VA (Department of Veterans Affairs) and DoD. 2009. VA/DoD clinical practice guideline for management of substance use disorders. Washington, DC: VA and DoD.
402. VA and DoD. 2010. VA/DoD clinical practice guideline for management of opioid therapy for chronic pain. Washington, DC: VA and DoD.
403. Valente, T. W., C. P. Chou, and M. A. Pentz. 2007. Community coalitions as a system: Effects of network change on adoption of evidence-based substance abuse prevention. American Journal of Public Health 97 (5):880-886.
404. Weinick, R. M., E. B. Beckjord, C. M. Farmer, L. T. Martin, E. M. Gillen, J. D. Acosta, M. Fisher, J. Garnett, G. C. Gonzalez, T. C. Helmus, L. H. Jaycox, K. A. Reynolds, N. Salcedo and D. M. Scharf. 2011. Programs addressing psychological health and traumatic brain injury among U.S. military servicemembers and their families. Santa Monica, CA: RAND Corporation.
405. Aday, L. A., and R. Andersen. 1974. A framework for the study of access to medical care. Health Services Research 9 (3):208-220.
406. Bray, R. M., M. R. Pemberton, L. L. Hourani, M. Witt, K. L. Olmsted, J. M. Brown, B. Weimer, M. E. Lance, M. E. Marsden, and S. Scheffler. 2009. Department of Defense survey of health related behaviors among active duty military personnel. Research Triangle Park, NC: RTI International.
407. Burnett-Zeigler, I., M. Ilgen, M. Valenstein, K. Zivin, L. Gorman, A. Blow, S. Duffy, and S. Chermack. 2011. Prevalence and correlates of alcohol misuse among returning Afghanistan and Iraq veterans. Addictive Behaviors 36 (8):801-806.
408. Defense Health Board. 2011. Psychotropic medication prescription practices and use and complementary and alternative medicine use. Falls Church, VA: Defense Health Board.
409. Dickstein, B. D., D. S. Vogt, S. Handa, and B. T. Litz. 2010. Targeting self-stigma in returning military personnel and veterans: A review of intervention strategies. Military Psychology 22 (2):224-236.
410. DoD (Department of Defense). 1985. Instruction 1010.6: Rehabilitation and referral services for alcohol and drug abusers. Washington, DC: DoD.
411. DoD. 1997. Directive 1010.4: Drug and alcohol abuse by DoD personnel. Washington, DC: DoD.
412. DoD. 2007. An achievable vision: Report of the Department of Defense Task Force on Mental Health. Washington, DC: DoD Task Force on Mental Health.
413. DoD. 2011a. Instruction 6490.08: Command notification requirements to dispel stigma in providing mental health care to service members. Washington, DC: DoD.
414. DoD. 2011b. Comprehensive plan on prevention, diagnosis, and treatment of substance use disorders and disposition of substance use offenders in the armed forces. Washington DC: Office of the Under Secretary of Defense.
415. DoD. 2012. Deployment medication information resource page. http://pec.ha.osd.mil/pmart/deployment.php (accessed July 11, 2012).
416. GAO (Government Accountability Office). 2011a. DoD and VA health care: Action needed to strengthen integration across care coordination and case management programs.
417. GAO. 2011b. VA mental health number of veterans receiving care, barriers faced, and efforts to increase access: Report to the ranking member, Committee on Veterans Affairs, House of Representatives. Washington, DC: GAO.
418. Gibbs, D. A., K. L. Rae Olmsted, J. M. Brown, and A. M. Clinton-Sherrod. 2011. Dynamics of stigma for alcohol and mental health treatment among Army soldiers. Military Psychology 23 (1):36-51.
419. Hoge, C. W., C. A. Castro, S. C. Messer, D. McGurk, D. I. Cotting, and R. L. Koffman. 2004. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. New England Journal of Medicine 351 (1):13-22.
420. Hser, Y. I., M. D. Anglin, C. Grella, D. Longshore, and M. L. Prendergast. 1997. Drug treatment careers: A conceptual framework and existing research findings. Journal of Substance Abuse Treatment 14 (6):543-558.
421. IOM (Institute of Medicine). 2006. Improving the quality of health care for mental and substance-use conditions: Quality chasm series. Washington, DC: The National Academies Press.
422. Kennell, D., A. Brooks, C. Witsberger, L. Cottrell, and K. Caney. 2009. Comparison of commercial, Medicaid, and TRICARE reimbursement rates for physicians. Falls Church, VA: Kennell and Associates, Inc.
423. KePRO. 2011. TRICARE Quality Monitoring Contractor (TQMC). http://tricare.kepro.com (accessed June 13, 2012).
424. Kim, P. Y., T. W. Britt, R. P. Klocko, L. A. Riviere, and A. B. Adler. 2011. Stigma, negative attitudes about treatment, and utilization of mental health care among soldiers. Military Psychology 23 (1):65-81.
425. Milliken, C. S., J. L. Auchterlonie, and C. W. Hoge. 2007. Longitudinal assessment of mental health problems among active and reserve component soldiers returning from the Iraq war. Journal of the American Medical Association 298 (18):2141-2148.
426. NQF (National Quality Forum). 2007. National voluntary consensus standards for the treatment of substance use conditions: Evidence-based treatment practices. Washington, DC: NQF.
427. SAMHSA (Substance Abuse and Mental Health Services Administration). 2011. Results from the 2010 National Survey on Drug Use and Health: Summary of national findings, national survey on drug use and health series. Rockville, MD: U.S. Department of Health and Human Services, SAMHSA, Center for Behaviorial Health Statistics and Quality.
428. Skidmore, W. C., and M. Roy. 2011. Practical considerations for addressing substance use disorders in veterans and service members. Social Work in Health Care 50(1):85-107.
429. Stecker, T., J. C. Fortney, F. Hamilton, and I. Ajzen. 2007. An assessment of beliefs about mental health care among veterans who served in Iraq. Psychiatric Services 58 (10):1358-1361.
430. Stokes, J. W., H. Greer, and P. S. Hammer. 2003. Combat stress control and force health protection. In Military preventive medicine: Mobilization and deployment. Vol. 1, edited by P. W. Kelley. Washington, DC: Office of The Surgeon General, Department of the Army.
431. TMA (TRICARE Management Activity). 2008. TRICARE policy manual 6010.57-M. Falls Church, VA: TMA.
432. United States Central Command. 2006. General order number 1B: Prohibited activities for U.S. Department of Defense personnel present within the United States Central Command area of responsibility. Macdill Air Force Base, FL: Office of the Commander, United States Central Command.
433. U.S. Army. 2008. Inspection of the Army's substance abuse program during unit deployments Washington, DC: Department of the Army.
434. U.S. Army. 2009. Army regulation 600-85: The Army substance abuse program. http://www.apd.army.mil/pdffiles/r600_85.pdf (accessed July 11, 2012).
435. U.S. Army. 2010. Health promotion, risk reduction, and suicide prevention report. Washington, DC: Army's Suicide Prevention Task Force.
436. U.S. Army. 2011. America's Army: At a strategic crossroads. Washington, DC: Department of the Army.
437. U.S. Army. 2012a. Army 2020: Generating health & discipline in the force. Washington, DC: Department of the Army.
438. U.S. Army. 2012b. Policy guidance on the assessment and treatment of post-traumatic stress disorder (PTSD). Fort Sam Houston, TX: Department of the Army.
439. U.S. Army Surgeon General. 2011. ALARACT 062/2011: Changes to length of authorized duration of controlled substance prescriptions in MEDCOM regulation 40-51. Washington DC: Department of the Army.
440. VA (Department of Veterans Affairs). 2008. Uniform mental health services in VA medical centers and clinics: VHA handbook 1160.01. Washington, DC: VA.
441. VA and DoD. 2009. VA/DoD clinical practice guideline for management of substance use disorders. Washington, DC: VA and DoD.
442. VA and DoD. 2010. VA/DoD clinical practice guideline for management of post-traumatic stress disorder and acute stress reaction. Washington, DC: VA and DoD.
443. Weinick, R. M., E. B. Beckjord, C. M. Farmer, L. T. Martin, E. M. Gillen, J. D. Acosta, M. P. Fisher, J. Garnett, G. C. Gonzalez, T. C. Helmus, L. H. Jaycox, K. A. Reynolds N. Salcedo, and D. M. Scharf. 2011. Programs addressing psychological health and traumatic brain injury among U.S. military service members and their families. Santa Monica, CA: RAND Corporation.
444. Weisner, C. 1990. Coercion in alcohol treatment. In Broadening the base of treatment for alcohol problems. Washington, DC: National Academy Press. Pp. 579-607.
445. Weisner, C., and H. Matzger. 2002. A prospective study of the factors influencing entry to alcohol and drug treatment. Journal of Behavioral Health Services and Research 29 (2):126-137.
446. Weisner, C., and L. A. Schmidt. 2001. Rethinking access to alcohol treatment. In Recent developments in alcoholism. Vol. 15, edited by M. Galanter. New York: Kluwer Academic/Plenham. Pp. 107-136.
447. Alcoholics Anonymous World Services. 1939. Alcoholics Anonymous. New York: Works Publishing, Inc.
448. Birch and Davis Associates, Inc. 1984. Development of model professional standards for counselor credentialing (Vol. 1). Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration National Institute on Alcohol Abuse and Alcoholism.
449. Camp, J. M., and N. R. Kurtz. 1982. Redirecting manpower for alcoholism treatment. In Prevention, intervention and treatment: Concerns and models. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Alcohol Abuse and Alcoholism. Pp. 371-397.
450. DoD (Department of Defense). 2007. An achievable vision: Report of the Department of Defense Task Force on Mental Health. Washington, DC: DoD Task Force on Mental Health.
451. DoD. 2011. Comprehensive plan on prevention, diagnosis, and treatment of substance use disorders and disposition of substance use offenders in the armed forces. Washington DC: Office of the Under Secretary of Defense.
452. Eby, L. T., and T. C. Rothrauff-Laschober. 2012. The relationship between perceptions of organizational functioning and voluntary counselor turnover: A four-wave longitudinal study. Journal of Substance Abuse Treatment 42 (2):151-158.
453. GAO (Government Accountability Office). 2010. Military personnel: Enhanced collaboration and process improvements needed for determining military treatment facility medical personnel requirements. Washington, DC: U.S. Government Printing Office.
454. Harris, D. M., and L. M. Marr. 2011. The Psychological Health Risk-Adjusted Model for Staffing (PHRAMS): Update for version 3.0. Alexandria, VA: CNA Analysis and Solutions.
455. IC&RC (International Certification & Reciprocity Consortium). 2012. Setting global standards for addiction professionals http://internationalcredentialing.org (accessed May 28, 2012).
456. McCarty, D., B. E. Fuller, C. Arfken, M. Miller, E. V. Nunes, E. Edmundson, M. Copersino, A. Floyd, R. Forman, R. Laws, K. M. Magruder, M. Oyama, K. Prather, J. Sindelar, and W. W. Wendt. 2007. Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: Characteristics, opinions, and beliefs. Psychiatric Services 58(2):181-190.
457. McCarty, D., K. J. McConnell, and L. A. Schmidt. 2009. Policies for the treatment of alcohol and drug use disorders: A research agenda for 2010-2015. Princeton, NJ: Robert Wood Johnson Foundation.
458. Oordt, M. 2011. Air Force substance abuse policies and programs. Lackland Air Force Base, TX: Air Force Medical Operations Agency.
459. SAMHSA (Substance Abuse and Mental Health Services Administration). 1998. Addiction counseling competencies the knowledge, skills, and attitudes of professional practice. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service SAMHSA.
460. U.S. Air Force. 2010. Air Force alcohol and drug counselor certification handbook. Washington, DC: Department of the Air Force.
461. U.S. Air Force. 2011a. AFMS annual training on substance misuse and abuse for healthcare personnel. Washington, DC: Department of the Air Force.
462. U.S. Air Force. 2011b. Instruction 44-121: Alcohol and Drug Abuse Prevention and Treatment (ADAPT) program. Washington, DC: Department of the Air Force.
463. U.S. Air Force. 2011c. Instruction 44-172: Mental health. Washington, DC: Department of the Air Force.
464. U.S. Navy. 1999. BUMEDINST 5353.4A: Standards for provision of substance related disorder treatment services. Washington, DC: Bureau of Medicine, Department of the Navy.
465. U.S. Navy. 2009. Operation Navy Instruction 5350.4D: Navy alcohol and drug abuse prevention and control. Washington, DC: Department of the Navy.
466. U.S. Navy. 2011. Student guide for Navy Drug and Alcohol Counselor School. San Diego, CA: Navy Drug and Alcohol Counselor School.
467. VA (Department of Veterans Affairs) and DoD. 2009. VA/DoD clinical practice guideline for management of substance use disorders. Washington, DC: VA and DoD.
468. Bray, R. M., M. R. Pemberton, L. L. Hourani, M. Witt, K. L. Olmsted, J. M. Brown, B. Weimer, M. E. Lance, M. E. Marsden, and S. Scheffler. 2009. Department of Defense survey of health related behaviors among active duty military personnel. Research Triangle Park, NC: RTI International.
469. Cunningham, J. A., T. C. Wild, J. Cordingley, T. Van Mierlo, and K. Humphreys. 2009. A randomized controlled trial of an Internet-based intervention for alcohol abusers. Addiction 104 (12):2023-2032.
470. Defense Health Board. 2011. Psychotropic medication prescription practices and use and complementary and alternative medicine use. Falls Church, VA: Defense Health Board.
471. DoD (Department of Defense). 2007. An achievable vision: Report of the Department of Defense Task Force on Mental Health. Washington, DC: DoD Task Force on Mental Health.
472. DoD. 2011a. Instruction 6490.08: Command notification requirements to dispel stigma in providing mental health care to service members. Washington, DC: DoD.
473. DoD. 2011b. Comprehensive plan on prevention, diagnosis, and treatment of substance use disorders and disposition of substance use offenders in the armed forces. Washington, DC: Office of the Under Secretary of Defense.
474. DoD. 2011c. TRICARE: Removal of the prohibition to use addictive drugs in the maintenance treatment of substance dependence in TRICARE beneficiaries. Federal Register. https://www.federalregister.gov/articles/2011/12/29/2011-33106/tricare-removal-of-theprohibition-to-use-addictive-drugs-in-the-maintenance-treatment-of-substance#p-3 (accessed August 6, 2012).
475. DuPont, R. L., A. T. McLellan, W. L. White, L. J. Merlo, and M. S. Gold. 2009. Setting the standard for recovery: Physicians' health programs. Journal of Substance Abuse Treatment 36 (2):159-171.
476. Gibbs, D. A., and K. L. Rae Olmsted. 2011. Preliminary examination of the confidential alcohol treatment and education program. Military Psychology 23(1):97-111.
477. Godley, M. D., V. H. Coleman-Cowger, J. C. Titus, R. R. Funk, and M. G. Orndorff. 2010. A randomized controlled trial of telephone continuing care. Journal of Substance Abuse Treatment 38 (1):74-82.
478. Goldman, H. H., R. G. Frank, M. A. Burnam, H. A. Huskamp, M. S. Ridgely, S. L. T. Normand, A. S. Young, C. L. Barry, V. Azzone, A. B. Busch, S. T. Azrin, G. Moran, C. Lichtenstein, and M. Blasinsky. 2006. Behavioral health insurance parity for federal employees. New England Journal of Medicine 354 (13):1378-1386.
479. Humphreys, J., J. Y. Tsoh, M. A. Kohn, and B. Gerbert. 2011. Increasing discussions of intimate partner violence in prenatal care using Video Doctor plus provider cueing: A randomized, controlled trial. Women's Health Issues 21 (2):136-144.
480. IOM (Institute of Medicine). 1990. Broadening the base of treatment for alcohol problems. Washington, DC: National Academy Press.
481. IOM. 1994. Under the influence? Drugs and the American work force. Washington, DC: National Academy Press.
482. Jackson, R. A., N. E. Stotland, A. B. Caughey, and B. Gerbert. 2011. Improving diet and exercise in pregnancy with Video Doctor counseling: A randomized trial. Patient Education and Counseling 83 (2):203-209.
483. Kaner, E. F. S., H. O. Dickinson, F. R. Beyer, F. Campbell, C. Schlesinger, N. Heather, J. B. Saunders, B. Burnand, and E. D. Pienaar. 2009. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database of Systematic Reviews 1.
484. Martell, B. A., P. G. O'Connor, R. D. Kerns, W. C. Becker, K. H. Morales, T. R. Kosten, and D. A. Fiellin. 2007. Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Annals of Internal Medicine 146 (2):116-127.
485. McConnell, K. J., S. H. Gast, M. S. Ridgely, N. Wallace, N. Jacuzzi, T. Rieckmann, B. H. McFarland, and D. McCarty. 2012. Behavioral health insurance parity: Does Oregon's experience presage the national experience with the Mental Health Parity and Addiction Equity Act? American Journal of Psychiatry 169 (1):31-38.
486. McLellan, A. T., G. S. Skipper, M. Campbell, and R. L. DuPont. 2008. Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States. British Medical Journal 337 (7679):1154-1156.
487. Mee-Lee, D., ed. 2007. ASAM patient placement criteria for the treatment of substance-related disorders (2nd ed. rev.). Chevy Chase, MD: American Society of Addiction Medicine.
488. NQF (National Quality Forum). 2007. National voluntary consensus standards for the treatment of substance use conditions: Evidence-based treatment practices. Washington, DC: NQF.
489. NRC (National Research Council) and IOM. 2009. Preventing mental, emotional, and behavioral disorders among young people: Progress and possibilities. Washington, DC: The National Academies Press.
490. Polen, M. R., E. P. Whitlock, J. P. Wisdom, P. Nygren, and C. Bougatsos. 2008. Screening in primary care settings for illicit drug use: Staged systematic review for the United States Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality.
491. Tsoh, J. Y., M. A. Kohn, and B. Gerbert. 2010. Promoting smoking cessation in pregnancy with Video Doctor plus provider cueing: A randomized trial. Acta obstetricia et gynecologica Scandinavica 89 (4):515-523.
492. U.S. Army. 2010. Pain Management Task Force: Final report. Falls Church, VA: Office of the Army Surgeon General.
493. U.S. Army Surgeon General. 2011. ALARACT 062/2011: Changes to length of authorized duration of controlled substance prescriptions in MEDCOM regulation 40-51. Washington DC: Department of the Army.
494. VA and DoD. 2009. VA/DoD clinical practice guideline for management of substance use disorders. Washington, DC: VA and DoD.
495. VA and DoD. 2010. VA/DoD clinical practice guideline for management of opioid therapy for chronic pain. Washington, DC: VA and DoD.
496. Weinick, R. M., E. B. Beckjord, C. M. Farmer, L. T. Martin, E. M. Gillen, J. D. Acosta, M. P. Fisher, J. Garnett, G. C. Gonzalez, T. C. Helmus, L. H. Jaycox, K. A. Reynolds N. Salcedo, and D. M. Scharf. 2011. Programs addressing psychological health and traumatic brain injury among U.S. military service members and their families. Santa Monica, CA: RAND Corporation.
497. Whitlock, E. P., C. A. Green, M. R. Polen, A. Berg, J. Klein, A. Siu, and C. T. Orleans. 2004. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use. Rockville, MD: Agency for Healthcare Research and Quality.